Rank	NCT Number	Title	Recruitment	Study Results	Conditions	Interventions	Sponsor/Collaborators	Gender	Age Groups	Phases	Enrollment	Funded Bys	Study Types	Study Designs	Other IDs	First Received	Start Date	Completion Date	Last Updated	Last Verified	Results First Received	Acronym	Primary Completion Date	Outcome Measures	URL
1	NCT02132312	A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement	Recruiting	No Results Available	Unilateral Cataract Extraction|Congenital Cataract	Drug: OMS302|Drug: Phenylephrine HCl	Omeros Corporation	Both	Child	Phase 3	60	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	OMS302-ILR-007	May 1, 2014	July 2014	January 2017	October 15, 2015	October 2015	No Study Results Posted	ILR7	December 2016	Intraoperative pupil diameter|Acute postoperative pain|Safety as measured by adverse events	https://ClinicalTrials.gov/show/NCT02132312
2	NCT02110212	Femtosecond Laser for Cataract Surgery	Terminated	No Results Available	Cataract	Procedure: U/S Surgery and CCC|Device: FS Laser Surgery	Abbott Medical Optics	Both	Adult|Senior	Phase 3	17	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	OMC-C-3.0	April 8, 2014	April 2011	February 2014	June 27, 2014	June 2014	No Study Results Posted	null	December 2011	Capsulotomy Dimension|Cumulative Dissipated Energy (CDE)	https://ClinicalTrials.gov/show/NCT02110212
3	NCT01878838	The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.	Completed	No Results Available	Nuclear Sclerosis of the Lens|Posterior Subcapsular Cataract|Cortical Cataract	Procedure: Femtosecond Laser Assisted Cataract Surgery w/ Catalys Laser|Procedure: Femtosecond Laser Assisted Cataract Surgery w/ LenSx Laser	Steve H. Linn, OD|Hoopes Vision	Both	Adult|Senior		45	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Crossover Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	HV-AVO1	June 12, 2013	April 2013	January 2014	August 18, 2015	August 2015	No Study Results Posted	null	December 2013	Cumulative Dissipated Energy|Complete Laser Capsulotomy	https://ClinicalTrials.gov/show/NCT01878838
4	NCT01841957	Immediate Simultaneous Bilateral Cataract Surgery	Recruiting	No Results Available	Bilateral Cataract	Procedure: ISBCS|Procedure: DSBCS	Sloan W. Rush, MD|Panhandle Eye Group, LLP	Both	Adult|Senior		2000	Other	Interventional	Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	2	April 18, 2013	April 2013	null	October 28, 2014	October 2014	No Study Results Posted	ISBCS	April 2016	Visual acuity|Recovery time and number of post-operative visits	https://ClinicalTrials.gov/show/NCT01841957
5	NCT01832311	Protein Profile of Immunoregulatory Factors in Diabetic Cataract	Completed	No Results Available	Cataract|Type 2 Diabetes Mellitus	Drug: Ketorolac	University of Zagreb	Both	Child|Adult|Senior	Phase 4	61	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Supportive Care|Masking: Open Label	108-1080229-0142	April 5, 2013	January 2009	December 2012	April 10, 2013	April 2013	No Study Results Posted	null	December 2011	serum level of interleukin-10|serum level of monocyte chemotactic protein-1|serum level of interleukin-17|serum level of Fas ligand|serum level of vascular endothelial growth factor|level of interleukin-10 in aqueous humor|level of monocyte chemotactic protein-1 in aqueous humor|level of interleukin-17 in aqueous humor|level of Fas ligand in aqueous humor|level of vascular endothelial growth factor in aqueous humor|degree of corneal edema	https://ClinicalTrials.gov/show/NCT01832311
6	NCT02185807	Video-assisted Informed Consent for Cataract Surgery	Recruiting	No Results Available	Cataract|Surgery	Procedure: video-assisted group|Procedure: control group	 Guangzhou First Municipal People’s Hospital	Both	Child|Adult|Senior		80	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Outcomes Assessor)	GZFPH-IRB-2013-087	July 7, 2014	July 2014	March 2015	February 10, 2015	February 2015	No Study Results Posted	null	March 2015	overall patients satisfaction with informed concent|The proportion of patients refusing to sign consent|A 10-question cataract surgery knowledge measure	https://ClinicalTrials.gov/show/NCT02185807
7	NCT01844258	Modified Surgical Techniques for Pediatric Cataract Treatment	Completed	No Results Available	Cataract	Procedure: Modified technique|Procedure: Traditional technique	Sun Yat-sen University	Both	Child		37	Other	Interventional	Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	CCPMOH2010-China3	April 28, 2013	March 2013	January 2014	February 23, 2014	February 2014	No Study Results Posted	null	December 2013	Incidence of opacification of the visual axis|Visual function in eyes treated for cataract	https://ClinicalTrials.gov/show/NCT01844258
8	NCT02363530	Corneal Protect Used During Cataract Surgery	Recruiting	No Results Available	Cataract	Device: Hydroxypropyl ethylcellulose (HPMC) 2% gel	Second Affiliated Hospital, School of Medicine, Zhejiang University	Both	Adult|Senior		100	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety Study|Intervention Model: Parallel Assignment|Primary Purpose: Basic Science|Masking: Double Blind (Subject, Investigator)	Corneal Protect	February 5, 2015	November 2014	May 2015	February 9, 2015	February 2015	No Study Results Posted	CPUDCS	April 2015	change from baseline dry eye condition at 1 month|Intraoperative corneal clarity|change from baseline corneal damage at 1 month|Inflammation|change from baseline dry eye condition at 1 week	https://ClinicalTrials.gov/show/NCT02363530
9	NCT01998698	Monovision vs Multifocal Lens Insertion in Cataract Patients	Completed	No Results Available	Cataract	Procedure: Phacoemulsification surgery|Procedure: Phacoemulsification surgery	Democritus University of Thrace	Both	Adult|Senior		60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	192/19-11-2013	November 19, 2013	March 2013	September 2013	November 29, 2013	November 2013	No Study Results Posted	null	September 2013	VF14 score|Distant Visual Acuity|Near Vision visual acuity	https://ClinicalTrials.gov/show/NCT01998698
10	NCT02304900	Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep	Completed	No Results Available	Cataract	Other: white implant|Other: yellow implant	University Hospital, Tours	Both	Adult|Senior	Phase 3	400	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	PHRI09-PJP / IOL et sommeil	November 27, 2014	December 2009	December 2012	November 27, 2014	November 2014	No Study Results Posted	IOL et sommeil	December 2011	Variation between before and 2 months after surgery sleep time|Variation between before and 2 months after surgery the number of hours of sleep|Variation between before and 2 months after surgery of the quality of sleep|Variation between before and 2 months after surgery the mood evaluation score	https://ClinicalTrials.gov/show/NCT02304900
11	NCT02423668	Pseudophakic Anterior Chamber Depth Measurement in Second Eye Refinement Cataract Surgery	Completed	No Results Available	Cataract	Procedure: 50% Partial adjustment|Procedure: No adjustment|Procedure: Full adjustment	Centro Hospitalar do Baixo Vouga	Both	Adult|Senior		88	Other	Observational	Observational Model: Cohort|Time Perspective: Retrospective	CHBaixoVouga3	April 19, 2015	January 2015	March 2015	April 21, 2015	April 2015	No Study Results Posted	null	March 2015	Second eye mean absolute error	https://ClinicalTrials.gov/show/NCT02423668
12	NCT02155270	Impact of a Corneal Pre-cut on Wound Architecture and Astigmatism in Cataract Surgery - a Pilot Study	Recruiting	No Results Available	Cataract	Procedure: Corneal precut 600µm|Procedure: Corneal stabincision	Prim. Prof. Dr. Oliver Findl, MBA|Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior		20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label	Precut	June 2, 2014	June 2014	March 2015	June 2, 2014	June 2014	No Study Results Posted	null	March 2015	Correlation between a wound architecture score and the post-operative astigmatism for the "pre-cut" group and the "stab-incision" group|Morphological changes over time	https://ClinicalTrials.gov/show/NCT02155270
13	NCT01769313	A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract Surgery	Completed	No Results Available	Cataract	Device: Laser-assisted cataract surgery|Device: Manually performed cataract surgery	Technolas Perfect Vision GmbH	Both	Adult|Senior	Phase 4	30	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Caregiver)	1202	January 14, 2013	January 2013	October 2014	October 30, 2014	October 2014	No Study Results Posted	null	October 2014	ΔROverlap is different between Group A and Group B|ΔELP is different between Group A and Group B|ΔFlare is different between Group A and Group B|SEQ Prediction Error is different between Group A and Group B	https://ClinicalTrials.gov/show/NCT01769313
14	NCT01847638	Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery	Recruiting	No Results Available	Cataract|Retinal Edema|Inflammation	Drug: Prolensa (bromfenac 0.07%)|Drug: Ilevro (nepafenac 0.3%)	Melissa Toyos, MD|Bausch & Lomb Incorporated|Discover Vision Centers	Both	Adult|Senior		50	Other|Industry	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Investigator)	MMT-2013	April 16, 2013	April 2013	December 2015	June 10, 2015	June 2015	No Study Results Posted	QD	December 2015	Treatment of inflammation associated with cataract surgery|Visual Acuity	https://ClinicalTrials.gov/show/NCT01847638
15	NCT02096627	Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery	Not yet recruiting	No Results Available	Cataract		Johns Hopkins University	Both	Adult|Senior		720	Other	Observational	Observational Model: Case Control|Time Perspective: Prospective	NA_00089916	March 16, 2014	May 2014	August 2016	March 23, 2014	March 2014	No Study Results Posted	null	May 2016	endothelial cell density three months after conventional CEIOL or FLACS compared to baseline	https://ClinicalTrials.gov/show/NCT02096627
16	NCT02304861	Viscoat Versus Visthesia. A Comparative Study of Post-cataract Endothelial Cell Loss	Completed	No Results Available	Cataract	Procedure: Viscoat|Procedure: Visthesia	Democritus University of Thrace	Both	Adult|Senior		80	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Single Blind (Outcomes Assessor)	visco07012eit	November 11, 2014	January 2014	November 2014	December 1, 2014	November 2014	No Study Results Posted	null	June 2014	Endothelial Cell Count (ECD)|Endothelial Cell pattern (ECP)|Central corneal edema (CCE)	https://ClinicalTrials.gov/show/NCT02304861
17	NCT01763151	Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism	Completed	No Results Available	Cataract|Corneal Astigmatism	Device: toric IOL|Procedure: IOL combined with opposite clear corneal incision (OCCI)	Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior	Phase 4	55	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	Viros_Askin	January 6, 2013	September 2010	December 2012	January 8, 2013	January 2013	No Study Results Posted	null	August 2012	Postoperative residual astigmatism|uncorrected distance visual acuity (UDVA)	https://ClinicalTrials.gov/show/NCT01763151
18	NCT02128113	RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD	Completed	No Results Available	Corneal Endothelial Cell Loss|Ocular Pain|Ocular Inflammation|Cataract Surgery	Drug: Placebo|Drug: 0.5% RTA 408 Ophthalmic Suspension|Drug: 1% RTA 408 Ophthalmic Suspension	Reata Pharmaceuticals, Inc.|AbbVie	Both	Adult|Senior	Phase 2	304	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Prevention|Masking: Double Blind (Subject, Investigator)	RTA 408-C-1309	April 28, 2014	May 2014	April 2015	June 23, 2015	June 2015	No Study Results Posted	null	February 2015	Count of corneal endothelial cells|Measure of inflammation|Measure of pain	https://ClinicalTrials.gov/show/NCT02128113
19	NCT02124603	Microbiological Evaluation of the Ocular Flora Before Cataract Surgery	Completed	Has Results	Disorders of the Eye Following Cataract Surgery		SIFI SpA	Both	Adult|Senior		120	Industry	Observational	Observational Model: Case-Only|Time Perspective: Cross-Sectional	041SI	April 23, 2014	April 2014	October 2014	August 27, 2015	August 2015	July 20, 2015	null	October 2014	Positive Culture in Subjects Scheduled for Cataract Surgery|Antibiotic Susceptibility|Eradication Rate	https://ClinicalTrials.gov/show/NCT02124603
20	NCT02253017	Evaluation of Therapeutic Strategies in Pediatric Cataract Surgery	Recruiting	No Results Available	Children Operated on for Cataract in Ophthalmology at Necker Hospital.	Other: Children operated on for cataract	Assistance Publique - Hôpitaux de Paris	Both	Child		60	Other	Observational	Observational Model: Cohort|Time Perspective: Prospective	2014-06-13	September 26, 2014	September 2014	null	July 27, 2015	July 2015	No Study Results Posted	EP3C	September 2022	Assessment practices in Pediatric Cataract Surgery.|Type of surgery and surgical procedures|Type of implant|Age at implantation|Distance visual acuity	https://ClinicalTrials.gov/show/NCT02253017
21	NCT02206594	Combined Cataract Surgery and Planned Descemetorhexis	Completed	No Results Available	Fuchs' Corneal Dystrophy|Cataract	Procedure: Descemetorhexis	Medical College of Wisconsin	Both	Adult|Senior		2	Other	Interventional	Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	MCW-EI-001	April 18, 2014	January 2014	null	August 20, 2015	July 2014	No Study Results Posted	null	August 2015	Corneal clarity as assessed by slit lamp photography|Resolution of edema as assessed by slit lamp photography	https://ClinicalTrials.gov/show/NCT02206594
22	NCT02182921	Evaluation of Cataract Surgery Outcome	Recruiting	No Results Available	Cataract|High Myopia		Evidence Based Cataract Study Group	Both	Child|Adult|Senior		20000	Other	Observational	Observational Model: Case Control|Time Perspective: Prospective	NSFC/YOUNG-81100653	June 24, 2014	August 2013	December 2020	February 10, 2015	February 2015	No Study Results Posted	null	December 2020	Change from baseline in visual acuity at one month after cataract surgery|Change from baseline in spherical equivalent at one month after cataract surgery|Change from baseline in visual acuity at six months after cataract surgery|Change from baseline in spherical equivalent at six months after cataract surgery|Change from baseline in wavefront aberration at one month after cataract surgery|Change from baseline in contrast sensitivity at one month after cataract surgery|Change from baseline in intraocular light scattering at one month after cataract surgery|Change from baseline in wavefront aberration at six months after cataract surgery|Change from baseline in contrast sensitivity at six months after cataract surgery|Change from baseline in intraocular light scattering at six months after cataract surgery	https://ClinicalTrials.gov/show/NCT02182921
23	NCT01800708	Cataract Surgery With Intracameral Triamcinolone in Infants	Completed	No Results Available	Cataract	Drug: Triamcinolone acetonide|Drug: Prednisolone syrup	Fundação Altino Ventura	Both	Child		60	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	1	February 25, 2013	January 2010	null	August 13, 2013	August 2013	No Study Results Posted	null	March 2013	Visual axis obscuration|Intraocular pressure	https://ClinicalTrials.gov/show/NCT01800708
24	NCT02351271	Cataract Surgery: Femto LDV Z8 Versus Conventional	Enrolling by invitation	No Results Available	Cataract	Device: Femto LDV Z8|Device: Manual capsulorhexis and lens fragmentation	Ziemer Ophthalmic Systems AG	Both	Adult|Senior		130	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	FL5940-0996	January 16, 2015	February 2015	September 2015	July 17, 2015	July 2015	No Study Results Posted	COMFORT	July 2015	Effective Phaco Time (EPT)|Ease of phacoemulsification (investigator perception - ease of phacoemulsification during surgery for eyes receiving Int A vs eyes receiving Int B p<0.05 considered positive for superior efficacy of application of Femto LDV Z8 over manual procedure)|Completeness of capsulotomy (based on a 4-level scale)	https://ClinicalTrials.gov/show/NCT02351271
25	NCT01774474	PRevention of Macular EDema After Cataract Surgery	Recruiting	No Results Available	Cystoid Macular Edema|Cataract|Diabetes Mellitus	Drug: Bromfenac|Drug: Dexamethasone|Drug: Bevacizumab|Drug: Triamcinolone Acetonide	Maastricht University Medical Center|European Society of Cataract and Refractive Surgeons	Both	Adult|Senior	Phase 3	1350	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Prevention|Masking: Double Blind (Subject, Investigator)	NL42463.068.12	January 7, 2013	July 2013	October 2016	April 9, 2015	April 2015	No Study Results Posted	PREMED	October 2016	Change in central subfield mean macular thickness as a measurement of efficacy|No. of subjects developing clinically significant macular edema as a measurement of efficacy	https://ClinicalTrials.gov/show/NCT01774474
26	NCT02277314	Manual Small Incision Cataract Surgery Outcomes in an Educational Setting	Recruiting	No Results Available	Cataracts	Procedure: Manual Small Incision Cataract Surgery	University of Arizona	Both	Adult|Senior		100	Other	Interventional	Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	1404277367	October 24, 2014	April 2014	April 2015	October 24, 2014	October 2014	No Study Results Posted	MSICS	April 2015	Manual Small Incision Cataract Surgery with outcomes of 20/40 or better at the end of a year and with spectacle correction	https://ClinicalTrials.gov/show/NCT02277314
27	NCT01824927	Pain Expression in the Perioperative Period of Cataract Surgery	Recruiting	No Results Available	Cataract|Surgery|Eye Pain	Procedure: First eye (FE)|Procedure: Second eye (SE)|Drug: Steroids eye drops	Evidence Based Cataract Study Group	Both	Adult|Senior		150	Other	Interventional	Allocation: Non-Randomized|Endpoint Classification: Bio-availability Study|Intervention Model: Parallel Assignment|Primary Purpose: Supportive Care|Masking: Single Blind (Subject)	EBCS001|NSFC81200669	April 2, 2013	January 2013	null	April 4, 2013	April 2013	No Study Results Posted	null	May 2013	Post operative pain level	https://ClinicalTrials.gov/show/NCT01824927
28	NCT02071147	RCT of Follow up Following Cataract Extraction	Recruiting	No Results Available	Cataract	Other: No Clinical Follow up|Other: Quality of Life questionnaire|Other: Patient satisfaction Questionnaire	South Devon Healthcare NHS Foundation Trust	Both	Adult|Senior		400	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety Study|Intervention Model: Parallel Assignment|Primary Purpose: Supportive Care|Masking: Single Blind (Caregiver)	14/02/050	February 21, 2014	February 2014	December 2015	May 18, 2015	May 2015	No Study Results Posted	null	December 2015	Corrected distance visual acuity (VA)|Vision-related quality of life impairment measures are the VCM1 and Catquest questionnaires|Post operative complication rate between the two groups|Post operative patient satisfaction between the two groups	https://ClinicalTrials.gov/show/NCT02071147
29	NCT02445274	Two Different Cataract Surgical Procedures to Prevent Posterior Capsule Opacification	Recruiting	No Results Available	Cataract|Posterior Capsule Opacification	Procedure: Anterior lens capsule was reserved	Sun Yat-sen University	Both	Adult|Senior		240	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	2015MEKY046	May 4, 2015	May 2015	August 2016	May 29, 2015	May 2015	No Study Results Posted	null	August 2016	Change from Baseline in posterior capsule opacification grading score|Change from Baseline in central posterior capsule thickness|Change from Baseline in central posterior capsule density	https://ClinicalTrials.gov/show/NCT02445274
30	NCT02492659	Clinical Research of Femtosecond Laser-Assisted Cataract Surgery	Completed	No Results Available	Cataracts	Procedure: femtosecond laser-assisted cataract surgery|Procedure: conventional phacoemulsification	Wenzhou Medical University	Both	Adult|Senior		54	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Single Blind (Investigator)	Femtosecond Laser	June 19, 2015	October 2013	June 2014	July 8, 2015	July 2015	No Study Results Posted	FLACS	March 2014	the proteins in the aqueous humor after femtosecond laser operation|the electrolyte in the aqueous humor after femtosecond laser operation|morphology of the anterior capsule after femtosecond laser operation	https://ClinicalTrials.gov/show/NCT02492659
31	NCT02023437	Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract Surgery	Completed	No Results Available	Cataract	Device: Femtosecond laser cataract surgery|Device: Manual cataract surgery	Technolas Perfect Vision GmbH	Both	Adult|Senior	Phase 4	132	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	1304_3M	December 6, 2013	December 2013	March 2014	May 22, 2014	May 2014	No Study Results Posted	null	March 2014	Adverse Events	https://ClinicalTrials.gov/show/NCT02023437
32	NCT01808547	Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects	Completed	No Results Available	Cataract	Drug: ISV-303|Other: DuraSite Vehicle	InSite Vision	Both	Adult|Senior	Phase 3	268	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Basic Science|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	C-12-303-004	March 7, 2013	April 2013	November 2013	March 30, 2015	March 2015	No Study Results Posted	null	November 2013	Post-surgical ocular inflammation|Post -surgical ocular pain	https://ClinicalTrials.gov/show/NCT01808547
33	NCT01946581	Retrospective Patient Satisfaction Survey in Subjects With Tecnis Intra Ocular Lenses and Cataracts Surgery	Recruiting	No Results Available	Cataract	Procedure: Cataract Surgery	MDbackline, LLC	Both	Adult|Senior		200	Other	Observational	Time Perspective: Retrospective	JH SAT 2013	September 12, 2013	May 2013	null	September 16, 2013	September 2013	No Study Results Posted	null	May 2014	Patient overall satisfaction post Cataract surgery	https://ClinicalTrials.gov/show/NCT01946581
34	NCT01859910	Compression of the Lid Margin Increase Microbial Contamination Risk of Patients Undergoing Cataract Surgery	Completed	No Results Available	Cataract	Procedure: compression and scrub of lid margin|Procedure: routine preparation for cataract	Orbis|Sun Yat-sen University	Both	Adult|Senior		306	Other	Interventional	Allocation: Randomized|Endpoint Classification: Bio-equivalence Study|Intervention Model: Parallel Assignment|Primary Purpose: Health Services Research|Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor)	Lid margin VS Cataract Surgery	May 20, 2013	October 2011	July 2012	May 20, 2013	May 2013	No Study Results Posted	null	April 2012	positive rate of culture|bacteria distribution of the culture	https://ClinicalTrials.gov/show/NCT01859910
35	NCT02328157	Combined 25-gauge Vitrectomy and Cataract Surgery With Toric Intraocular Lens With Idiopathic Epiretinal Membrane.	Recruiting	No Results Available	Cataract|Epiretinal Membrane|Corneal Astigmatism	Device: Vitrectomy with cataract surgery and toric IOL|Device: Vitrectomy with cataract surgery and common IOL	Kagawa University	Both	Child|Adult|Senior		30	Other	Interventional	Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	H26-061	December 13, 2014	January 2015	October 2018	September 1, 2015	September 2015	No Study Results Posted	null	October 2018	The degree of IOL axis rotation from the end of surgery	https://ClinicalTrials.gov/show/NCT02328157
36	NCT02101359	Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery	Completed	Has Results	Cataract	Drug: T2380|Drug: Mydriatics|Drug: Tetracaine	Laboratoires Thea	Both	Adult|Senior	Phase 3	609	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	LT2380-PIII-05/10	September 4, 2013	June 2011	May 2013	November 4, 2014	November 2014	September 19, 2014	null	January 2013	The Primary Efficacy Variable is Response Based on the Realisation of the Capsulorhexis Without Use of Any Additive Mydriatic Treatment.	https://ClinicalTrials.gov/show/NCT02101359
37	NCT02150460	A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at Kaduna, Nigeria	Completed	Has Results	Anaesthesia|Cataract	Procedure: One-site peribulbar injection|Procedure: Two- site peribulbar injection	National Eye Centre, Kaduna	Both	Adult|Senior	Phase 4	100	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator, Outcomes Assessor)	NECKAD/TRIALS/001/2012	May 26, 2014	October 2012	June 2013	March 15, 2015	May 2014	February 13, 2015	null	December 2012	Time Taken to Achieve Adequate Akinesia|Supplementary Injection(s)|Complications of Local Anaesthetic Injection|Pain Score for Local Anaesthetic Injection|Pain Score for Cataract Surgery|Volume of Anaesthetic Drug (ml)|Total Number of Injections|Surgeon Satisfaction Score for Local Anaesthetic Block|Acceptability of the Anaesthetic Block to the Subject|Duration of Cataract Surgery (Minutes)	https://ClinicalTrials.gov/show/NCT02150460
38	NCT02137161	Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery	Completed	No Results Available	Cataract|Pseudoexfoliation Syndrome	Drug: Dexamethasone+Tobramycin eye drop|Drug: Bromfenac eye drop	Arcispedale Santa Maria Nuova-IRCCS	Both	Adult|Senior	Phase 4	62	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	2013-002066-39	May 12, 2014	November 2013	October 2014	October 28, 2014	October 2014	No Study Results Posted	REPEX	October 2014	Change from baseline in anterior chamber inflammation measured by Laser Flare Photometry (photon counts per millisecond)|Proportion of patients with central macular thickness greater than 300 microns|Proportion of subjects with best corrected visual acuity equal to 20/20|Proportion of patients who had no ocular pain	https://ClinicalTrials.gov/show/NCT02137161
39	NCT02581046	Effect of the Timing of Cataract Surgery on Complications in Patients With Bilateral Congenital Cataracts	Completed	No Results Available	Cataract	Procedure: Phacomulsification lens removal cataract surgery without Intraocular lens(IOL) implantation at the age of 3month of the patients|Procedure: Phacomulsification lens removal cataract surgery without Intraocular lens(IOL) implantation at the age of 6 month of the patients|Drug: Subconjunctival dexamethasone and general anesthesia	Sun Yat-sen University|Ministry of Health, China	Both	Child		61	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Outcomes Assessor)	CCPMOH2010-China7	October 16, 2015	January 2011	December 2013	October 18, 2015	October 2015	No Study Results Posted	null	December 2013	Change from baseline in the central subfield thickness (CST) measured by Optical Coherence Tomography(OCT)|Change from baseline in the thickness of the inner retinal layer regions measured by Optical Coherence Tomography(OCT)|Change from baseline in the thickness of the outer retinal layer regions measured by Optical Coherence Tomography(OCT)|Number of participants with abnormal intraocular pressure or diagnosis with secondary glaucoma|Number of participants undergoing Nd:YAG laser capsulotomy due to severe posterior capsular opacification（PCO）	https://ClinicalTrials.gov/show/NCT02581046
40	NCT01778998	Impact of Incision Size and Architecture on Wound Stability and Astigmatism in Cataract Surgery: an Exploratory Study	Completed	No Results Available	Cataract	Procedure: MICS-group|Procedure: SICS-group|Procedure: SICS pre-cut|Procedure: SICS stab-incision	Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior		68	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Basic Science|Masking: Double Blind (Subject, Investigator, Outcomes Assessor)	INCISIONS	January 25, 2013	February 2012	September 2013	February 7, 2014	February 2014	No Study Results Posted	INCISIONS	September 2013	o Correlation between a wound architecture score (developed during the study) and the post-operative astigmatism for the "MICS", the "SICS", the "SICS pre-cut" and the "SICS stab-incision" group	https://ClinicalTrials.gov/show/NCT01778998
41	NCT01996839	Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery	Completed	No Results Available	Inflammation|Pain|Cataract	Drug: Loteprednol Etabonate Gel (BID)|Drug: Loteprednol Etabonate Gel (TID)|Drug: Vehicle (BID)|Drug: Vehicle (TID)	Bausch & Lomb Incorporated	Both	Adult|Senior	Phase 3	514	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	842	November 22, 2013	December 2013	July 2014	July 23, 2014	July 2014	No Study Results Posted	null	May 2014	Resolution of AC Cells|Pain|Resolution of AC cells|Resolution of AC Flare|Resolution of AC Cells and Flare	https://ClinicalTrials.gov/show/NCT01996839
42	NCT02523950	Staged and Combined Surgery for Cataract Patients With Corneal Endothelial Dysfunction	Recruiting	No Results Available	Cataract|Corneal Endothelial Keratopathy|Phacoemulfisication+IOL Implantation|Endothelial Keratopathy	Procedure: Staged phacoemulsification and DMEK|Procedure: Combined phacoemulsification and DMEK|Device: Intraocular lens (IOL) implantation	Haotian Lin|Sun Yat-sen University	Both	Adult|Senior		100	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	2015MEKY047	July 7, 2015	March 2015	December 2017	August 12, 2015	August 2015	No Study Results Posted	null	July 2017	Change from baseline in visual acuity measured by Snellen chart|Change from baseline in central corneal thickness measured by anterior segment OCT|Change from baseline in endothelial cell density measured by corneal specular microscopy|Change from baseline in endothelial graft attachment measured by anterior segment OCT|Change from baseline in corneal transparency measured by slit-lamp microscopy	https://ClinicalTrials.gov/show/NCT02523950
43	NCT02547623	Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery	Not yet recruiting	No Results Available	Cataract	Drug: Dexamethasone|Drug: Prednisolone	ICON Bioscience Inc	Both	Adult|Senior	Phase 3	180	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	C15-01	September 9, 2015	October 2015	December 2015	September 10, 2015	September 2015	No Study Results Posted	null	December 2015	Endothelial cell count as measured by specular microscopy	https://ClinicalTrials.gov/show/NCT02547623
44	NCT02208297	Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery	Completed	No Results Available	Inflammation|Pain|Cataract	Drug: Loteprednol Etabonate Gel (BID)|Drug: Vehicle Gel (BID)	Bausch & Lomb Incorporated	Both	Adult|Senior	Phase 3	322	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	843	August 1, 2014	September 2014	March 2015	August 4, 2015	March 2015	No Study Results Posted	null	March 2015	Resolution of AC Cells|Pain|Resolution of AC Flare|Resolution of AC Cells and Flare|Change of AC Cells and Flare|Treatment Failures	https://ClinicalTrials.gov/show/NCT02208297
45	NCT02067429	Limbal Relaxing Incision Versus Toric Intraocular Lens for Corneal Astigmatism During Cataract Surgery.	Recruiting	No Results Available	Astigmatism|Cataract	Procedure: Limbal Relaxing Incisions|Device: Toric Intraocular Lens	Christin Henein|Rayner Intraocular Lenses Limited|Sussex Eye Hospital	Both	Adult|Senior		80	Other|Industry	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Outcomes Assessor)	RCT135670	February 17, 2014	June 2014	null	November 27, 2014	November 2014	No Study Results Posted	null	December 2015	Unaided distance LogMAR visual acuity (UDVA)	https://ClinicalTrials.gov/show/NCT02067429
46	NCT02567565	Evaluation of Tear Film Lipid Layer Thickness Change After Cataract Surgery	Completed	No Results Available	Cataract Patients	Other: LipiView	Yonsei University	Both	Adult|Senior		60	Other	Observational	Observational Model: Case-Only|Time Perspective: Prospective	4-2015-0225	October 1, 2015	May 2015	October 2015	October 1, 2015	October 2015	No Study Results Posted	null	October 2015	tear film lipid layer thickness	https://ClinicalTrials.gov/show/NCT02567565
47	NCT02235272	Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation	Active, not recruiting	No Results Available	Inflammation|Pain|Cataract	Drug: XG-102|Drug: Placebo	Xigen SA	Both	Adult|Senior	Phase 3	300	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	SDD-1002-064	September 5, 2014	September 2014	July 2015	April 23, 2015	April 2015	No Study Results Posted	null	July 2015	Absence of anterior chamber cells for the 900µg XG-102 sub-conjunctival injection compared to vehicle|Absence of pain for the 900µg XG-102 compared to vehicle|Use of rescue medication	https://ClinicalTrials.gov/show/NCT02235272
48	NCT02508337	Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain	Recruiting	No Results Available	Inflammation|Pain|Cataract	Drug: XG-102|Drug: Placebo	Xigen SA	Both	Adult|Senior	Phase 3	300	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	SDD-1002-065	July 20, 2015	July 2015	January 2016	July 22, 2015	July 2015	No Study Results Posted	null	January 2016	Absence of anterior chamber cells|Pain scores as measured by the visual analog scale|Use of rescue medication|Number of patients with adverse events	https://ClinicalTrials.gov/show/NCT02508337
49	NCT02403206	Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts	Recruiting	No Results Available	Intumescent Cataract	Device: Femtosecond laser|Procedure: Continuous Curvilinear Capsulorhexis	Alcon Research	Both	Adult|Senior		425	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	CTW860-P001	March 26, 2015	March 2015	May 2016	September 25, 2015	September 2015	No Study Results Posted	null	May 2016	Percentage of capsular tears (anterior or posterior) during surgery|Operating time in the eye to complete entire cataract procedure	https://ClinicalTrials.gov/show/NCT02403206
50	NCT02329743	Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery	Recruiting	No Results Available	Inflammation|Pain|Cataract	Drug: RX-10045	A.T. Resolve SARL	Both	Adult|Senior	Phase 2	225	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	ATR-45-1401	December 23, 2014	December 2014	July 2015	April 9, 2015	April 2015	No Study Results Posted	null	June 2015	Proportion of subjects with clearing of anterior inflammation|Proportion of subjects reporting no ocular pain	https://ClinicalTrials.gov/show/NCT02329743
51	NCT01859702	Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients	Completed	Has Results	Cataract	Drug: Moxifloxacin 0.5%/Dexamethasone 0.1% ophthalmic solution	Alcon Research	Both	Adult|Senior	Phase 4	36	Industry	Interventional	Endpoint Classification: Pharmacokinetics Study|Intervention Model: Single Group Assignment|Primary Purpose: Basic Science|Masking: Open Label	RDG-11-235	May 20, 2013	April 2012	August 2012	June 6, 2013	June 2013	June 6, 2013	null	August 2012	Mean Aqueous Humor Concentration of Moxifloxacin	https://ClinicalTrials.gov/show/NCT01859702
52	NCT01898728	Comparison of the Effectiveness of Povidone-iodine in Reducing Conjunctival Bacterial Load Prior to Cataract Surgery in Patients Treated With a Lidocaine Gel Dilating Formulation Versus Eye Drops: A Randomized Controlled Trial	Active, not recruiting	No Results Available	Cataracts	Drug: topical povidone-iodine after premedication with topical liquid eye drops|Drug: topical povidone-iodine after premedication with topical gel	McMaster University	Both	Adult|Senior		104	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Investigator, Outcomes Assessor)	Lidocaine gel vs drops	July 7, 2013	December 2012	null	July 10, 2013	July 2013	No Study Results Posted	null	July 2013	The number of Colony Forming Units (CFUs)	https://ClinicalTrials.gov/show/NCT01898728
53	NCT02573610	Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery	Recruiting	No Results Available	Cataract Surgery	Drug: DE-108|Drug: Levofloxacin 0.5%	Santen Pharmaceutical Co., Ltd.	Both	Adult|Senior	Phase 3	430	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Prevention|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	DE-108	October 7, 2015	September 2015	null	October 9, 2015	October 2015	No Study Results Posted	null	September 2016	Change in the percentage of positive bacteriological test results (from Day -3 to Day 0)	https://ClinicalTrials.gov/show/NCT02573610
54	NCT02040129	Reduction of Corneal Astigmatism With Toric Intraocular Lens Implantation in Congenital Cataract	Completed	No Results Available	Congenital Cataract	Device: Acrysof Toric IOL	Kyungpook National University	Both	Child		4	Other	Interventional	Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	KNUH2014-01	January 16, 2014	January 2009	November 2009	January 16, 2014	January 2014	No Study Results Posted	null	January 2009	Change from baseline in astigmatism after cataract surgery at 24 months|Change from baseline in quality of vision after cataract surgery at 24 months.	https://ClinicalTrials.gov/show/NCT02040129
55	NCT02490267	Quality of Life in Children Glaucoma and Cataract	Recruiting	No Results Available	Paediatrics With Cataracts|Paediatrics With Glaucoma	Other: Quality of Life questionnaire	Moorfields Eye Hospital NHS Foundation Trust	Both	Child		200	Other	Observational	Observational Model: Case Control|Time Perspective: Prospective	DALA1020	June 25, 2015	June 2014	July 2015	July 7, 2015	June 2015	No Study Results Posted	null	July 2015	Incidence of babies requiring treatment for retinopathy of prematurity in the UK.|Demographic characteristics of babies that need treatment,|Outcome of the treatment at 1 year follow up: anatomical and functional|Type of treatment administered	https://ClinicalTrials.gov/show/NCT02490267
56	NCT01982006	Economic Evaluation of Femtosecond Laser Assisted Cataract Surgery	Recruiting	No Results Available	Cataract	Procedure: Cataract surgery with Phacoemulsification|Device: Femtosecond laser-assisted cataract surgery	University Hospital, Bordeaux	Both	Adult|Senior	Phase 3	1050	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	CHUBX 2012/23	October 21, 2013	October 2013	April 2016	January 12, 2015	January 2015	No Study Results Posted	FEMCAT	July 2015	Incremental Cost/effectiveness ratio defined as cost per incremental therapeutic success.|Quality of life|Learning curve of the femtosecond laser-assisted cataract surgery|Overall costs of cataract surgery in both arms from the hospital perspective|Incremental cost - Utility ratio defined as incremental Cost/QALY (Quality Adjusted Life Year) for healthcare insurance in both arms|No severe intraoperative or postoperative complications|Best Corrected Visual Acuity of 0 LogMAR|Refractive error inferior or equal to 0.75 diopter|Corneal surgically-induced astigmatism inferior or equal to 0.5 diopter and a postoperative change of astigmatism axis inferior or equal to 20°	https://ClinicalTrials.gov/show/NCT01982006
57	NCT01818037	Long-term Postoperative Outcomes After Bilateral Congenital Cataract Surgery in Eyes With Microphthalmos	Completed	No Results Available	Microphthalmos With Congenital Cataracts	Procedure: Cataract surgery	Iladevi Cataract and IOL Research Center	Both	Child		36	Other	Observational	Observational Model: Case-Only|Time Perspective: Prospective	13-002	March 21, 2013	January 2003	March 2013	March 25, 2013	March 2013	No Study Results Posted	null	March 2013	Glaucoma following cataract surgery|Posterior synechiae|visual axis obscuration|axial length rate of growth|central corneal thickness|visual acuity	https://ClinicalTrials.gov/show/NCT01818037
58	NCT02006888	The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery	Completed	No Results Available	Inflammation|Cataracts	Drug: IBI-10090|Drug: Placebo	ICON Bioscience Inc	Both	Adult|Senior	Phase 3	394	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	C13-04	December 5, 2013	January 2014	October 2014	March 23, 2015	March 2015	No Study Results Posted	null	October 2014	The primary efficacy outcome is anterior chamber cell clearing (ACC = 0) in the study eye at Day 8.	https://ClinicalTrials.gov/show/NCT02006888
59	NCT02434250	Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy	Not yet recruiting	No Results Available	Open Angle Glaucoma|Ocular Hypertension|Cataract	Procedure: Selective Laser Trabeculoplasty	University of Zurich	Both	Adult|Senior		800	Other	Interventional	Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	SLT after Phaco-ELT	January 29, 2015	May 2015	December 2016	April 29, 2015	April 2015	No Study Results Posted	SLT	December 2016	Efficacy as measured by decrease in intraocular pressure from baseline|Efficacy as measured by decrease in number of used hypotensive medications|Efficacy as increase in best corrected visual acuity	https://ClinicalTrials.gov/show/NCT02434250
60	NCT02571556	OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)	Not yet recruiting	No Results Available	Patients Having Undergone Unilateral Cataract Extraction and Implantation of a Monofocal	Drug: Experimental: Dexamethasone Phosphate Ophthalmic solution (40 mg/mL) delivered by ocular iontophoresis consisting of 4.0 mA-min at 1.5 mA	Eyegate Pharmaceuticals, Inc.	Both	Adult|Senior	Phase 1|Phase 2	20	Industry	Interventional	Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	EGP-437-008	October 6, 2015	November 2015	March 2016	October 6, 2015	October 2015	No Study Results Posted	null	January 2016	The proportion of subjects with an anterior chamber cell count of zero on Day 14|The proportion of subjects with a pain score of zero on Day 7	https://ClinicalTrials.gov/show/NCT02571556
61	NCT02561104	Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification Cataract Surgery	Not yet recruiting	No Results Available	Incipient Cataract|Senile Nuclear Sclerosis	Procedure: Laser-assisted cataract surgery.|Procedure: Traditional manual phacoemulsification	University of Texas Southwestern Medical Center	Both	Adult|Senior		180	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	STU 092014-020	September 24, 2015	September 2015	January 2017	September 24, 2015	August 2015	No Study Results Posted	null	August 2016	Complication rates|Visual Acuity|Patient benefit perception|Corneal Endothelial Cell Count (ECC)|Lens removal time	https://ClinicalTrials.gov/show/NCT02561104
62	NCT01848288	Intra-Operative Metrics With CENTURION® and INFINITI® Vision Systems	Completed	Has Results	Cataract	Device: CENTURION® Vision System (CVS)|Device: INFINITI® Vision System (IVS)	Alcon Research	Both	Adult|Senior		112	Industry	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single Blind (Subject)	M-13-006	May 1, 2013	July 2013	February 2014	March 18, 2015	March 2015	February 27, 2015	null	February 2014	Cumulative Dissipated Energy|Aspiration (ASP) Fluid Used|Aspiration Time	https://ClinicalTrials.gov/show/NCT01848288
63	NCT02138123	Intraocular Lens-shell Technique in Phacoemulsification	Completed	No Results Available	Cataract|Pseudoaphakia	Procedure: IOL-shell technique|Procedure: Conventional procedure	Sun Yat-sen University|National Natural Science Foundation of China	Both	Adult|Senior		80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Outcomes Assessor)	CCPMOH2010-China5	May 12, 2014	December 2011	June 2013	June 6, 2014	June 2014	No Study Results Posted	null	June 2013	Central corneal endothelial cell loss|central cornea thickness	https://ClinicalTrials.gov/show/NCT02138123
64	NCT01872611	Nepafenac Once Daily for Macular Edema - Study 2	Completed	No Results Available	Non-Proliferative Diabetic Retinopathy|Cataract	Drug: Nepafenac Ophthalmic Suspension, 0.3%|Other: Nepafenac Vehicle|Drug: Prednisolone acetate ophthalmic suspension	Alcon Research	Both	Adult|Senior	Phase 3	819	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	C-12-071|2013-001874-12	June 5, 2013	June 2013	May 2015	May 27, 2015	May 2015	No Study Results Posted	null	May 2015	Proportion of subjects with best-corrected visual acuity (BCVA) improvement of ≥ 15 letters from preoperative baseline to Day 14 and maintained through Day 90|Proportion of subjects who develop macular edema (defined as ≥ 30% increase from pre-operative baseline in central subfield macular thickness) within 90 days following cataract surgery|Proportion of subjects with BCVA improvement of ≥ 15 letters from preoperative baseline to Day 90|Proportion of subjects with BCVA improvement of ≥ 15 letters from preoperative baseline to Day 60	https://ClinicalTrials.gov/show/NCT01872611
65	NCT01853072	Nepafenac Once Daily for Macular Edema - Study 1	Completed	No Results Available	Non-Proliferative Diabetic Retinopathy|Cataract	Drug: Nepafenac Ophthalmic Suspension, 0.3%|Other: Nepafenac vehicle|Drug: Prednisolone acetate ophthalmic suspension	Alcon Research	Both	Adult|Senior	Phase 3	881	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	C-12-067	May 10, 2013	June 2013	May 2015	May 27, 2015	May 2015	No Study Results Posted	null	May 2015	Proportion of subjects with BCVA improvement of ≥ 15 letters from preoperative baseline to Day 14 and maintained through Day 90|Proportion of subjects who develop macular edema (defined as ≥ 30% increase from pre-operative baseline in central subfield macular thickness) within 90 days following cataract surgery|Proportion of subjects with BCVA improvement of ≥ 15 letters from preoperative baseline to Day 90|Proportion of subjects with BCVA improvement of ≥ 15 letters from preoperative baseline to Day 60	https://ClinicalTrials.gov/show/NCT01853072
66	NCT01887873	Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy	Recruiting	No Results Available	Open Angle Glaucoma|Cataract	Device: Hyaluronan Thiomer i.o. implant	Croma-Pharma GmbH	Both	Adult|Senior	Phase 1	16	Industry	Interventional	Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	OPHT150611	June 11, 2013	July 2012	null	July 29, 2014	June 2013	No Study Results Posted	null	October 2014	Safety|Efficacy	https://ClinicalTrials.gov/show/NCT01887873
67	NCT02131194	The Post-Vitrectomy Lenstatin™ Study	Active, not recruiting	No Results Available	Cataract, Nuclear Progressive	Dietary Supplement: Lenstatin|Drug: Placebo	Lenstatin LLC	Both	Adult|Senior		20	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Prevention|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	1-tunis	May 2, 2014	June 2014	November 2015	May 20, 2015	May 2015	No Study Results Posted	null	November 2015	Pentacam Nuclear Density Measurements	https://ClinicalTrials.gov/show/NCT02131194
68	NCT02028754	A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms	Completed	Has Results	Dry Eye Syndromes|Cataract	Drug: Sodium Carboxymethylcellulose|Drug: Levofloxacin|Drug: Prednisolone	Allergan	Both	Adult|Senior	Phase 4	180	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	CN-CMC-1101	January 6, 2014	July 2011	May 2013	March 19, 2014	March 2014	March 19, 2014	RLOTUS	May 2013	Tear Break-Up Time (TBUT) in the Study Eye|Fluorescein Staining Score in the Study Eye|Lissamine Green Staining Score in the Study Eye|Results of Schirmer I Test With Anesthetics in the Study Eye|Ocular Surface Disease Index (OSDI) Questionnaire Score in the Study Eye|Subjective Symptom Total Score in the Study Eye	https://ClinicalTrials.gov/show/NCT02028754
69	NCT02183831	Comparison of Clinical Outcomes After Cataract Surgery With and Without Capsular Tension Ring	Completed	No Results Available	Cataract	Device: Insertion of the capsular tension ring	Yonsei University	Both	Adult|Senior		52	Other	Observational	Observational Model: Case Control|Time Perspective: Retrospective	1-2014-0010	June 23, 2014	May 2014	June 2014	July 2, 2014	June 2014	No Study Results Posted	null	June 2014	Best corrected visual acuity|refractive error|Anterior chamber depth|Ocular aberrations|constrast sensitivity|posterior capsular opacity grades	https://ClinicalTrials.gov/show/NCT02183831
70	NCT02312362	High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP	Recruiting	No Results Available	Cataract|Glaucoma|POAG	Procedure: Combined sclerotomy ab interno and phaco|Procedure: Phacoemulsification with IOL implantation	Oertli Instrumente AG|University of Geneva, Switzerland	Both	Adult|Senior		108	Industry|Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	HFDS_PS_v9	December 5, 2014	November 2012	December 2016	December 5, 2014	December 2014	No Study Results Posted	HFDS_abinterno	June 2015	Intraocular pressure|visual acuity|decrease in anti glaucoma medications	https://ClinicalTrials.gov/show/NCT02312362
71	NCT02411487	Meibomian Gland Dysfunction (MGD) and Tear Cytokines After Cataract Surgery According to Preoperative Meibomian Gland Status	Recruiting	No Results Available	Cataract		Yonsei University	Both	Adult|Senior		55	Other	Observational	Observational Model: Case-Only|Time Perspective: Prospective	4-2014-1103	March 5, 2015	February 2015	August 2015	April 2, 2015	April 2015	No Study Results Posted	null	August 2015	inflammatory tear cytokine concentration|ocular surface staining|tear film break-up time,|conjunctival injection,|Schirmer's test I|ocular surface disease index	https://ClinicalTrials.gov/show/NCT02411487
72	NCT02502526	Comparison of Centurion® Vision System With Balanced Tip and the Infiniti® Vision System With the Mini Flared Kelman (MFK) Tip During Cataract Extraction Surgery of Hard Lenses	Recruiting	No Results Available	Cataracts	Device: Centurion® Vision System, 45° Balanced Tip|Device: Centurion® Vision System, 45° MFK Tip|Device: lnfiniti® Vision System, 45° MFK Tip|Device: INTREPID® Ultra infusion sleeve|Device: Ultra infusion sleeve	Alcon Research	Both	Adult|Senior		177	Industry	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	CTU424-P001	July 13, 2015	July 2015	April 2016	July 28, 2015	July 2015	No Study Results Posted	null	April 2016	Cumulative Dissipated Energy (CDE)|Balanced Salt Solution (BSS) Fluid Used	https://ClinicalTrials.gov/show/NCT02502526
73	NCT01991717	Victus Versus Conventional	Recruiting	No Results Available	Cataract	Device: Victus|Device: Conventional Phaco	Matthias Bolz|Technolas Perfect Vision GmbH|Augenabteilung Allgemeines Krankenhaus Linz	Both	Adult|Senior		50	Other|Industry	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Investigator)	13A06	November 18, 2013	December 2013	January 2015	January 20, 2014	January 2014	No Study Results Posted	null	January 2015	Effective Phaco Time|IOL overlap|IOL Centration	https://ClinicalTrials.gov/show/NCT01991717
74	NCT01872000	Binocular Vision in Monocular Pseudophakia	Recruiting	No Results Available	Cataract	Procedure: Cataract surgery	University of Oxford|Oxford University Hospitals NHS Trust	Both	Adult		40	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator, Outcomes Assessor)	BVMP2013	May 1, 2013	April 2013	December 2017	March 10, 2015	June 2013	No Study Results Posted	BVMP	April 2017	Extent of binocular vision at near working distance following IOL implantation.|Change in visual acuity and subjective visual comfort at distance, intermediate and near working distances following IOL implantation.	https://ClinicalTrials.gov/show/NCT01872000
75	NCT02396719	A Real-World Registry to Investigate the Performance of LenSx® Laser in Chinese Patients	Recruiting	No Results Available	Cataracts	Device: LenSx® Laser	Alcon Research	Both	Adult|Senior		1500	Industry	Observational	Time Perspective: Prospective	CTO130-P001	March 19, 2015	March 2015	April 2016	September 28, 2015	September 2015	No Study Results Posted	null	April 2016	Completion rate of a round anterior capsulotomy|Completion rate of lens fragmentation without additional segmentation after LenSx Laser procedure|Completion rate of intraocular lens (IOL) implantation|Completion rate of corneal incisions|Best-corrected distance visual acuity (BCDVA)|Percentage of patients with BCDVA of 20/20, 20/25, 20/40 or better at each visit	https://ClinicalTrials.gov/show/NCT02396719
76	NCT01971177	Addressing of Efficacy and Safety of Femtosecond-laser Assisted Versus Manual Lens Fragmentation Procedure	Completed	No Results Available	Cataract	Device: Femtosecond laser cataract surgery|Procedure: Manual cataract surgery	Technolas Perfect Vision GmbH	Both	Adult|Senior	Phase 4	136	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	1304	October 23, 2013	October 2013	February 2014	March 13, 2014	March 2014	No Study Results Posted	null	February 2014	Effective Phacoemulsification Time|Adverse Events	https://ClinicalTrials.gov/show/NCT01971177
77	NCT02260973	The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity	Recruiting	No Results Available	Cataract, Dry Eye Disease	Dietary Supplement: Omega-3 (Triglyceride form)	Physician Recommended Nutriceuticals	Both	Adult|Senior	Phase 2|Phase 3	150	Industry	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Primary Purpose: Supportive Care|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	PRN 20145	October 6, 2014	November 2014	null	June 5, 2015	June 2015	No Study Results Posted	null	April 2016	Visual Acuity	https://ClinicalTrials.gov/show/NCT02260973
78	NCT02158325	Capsulorhexis Size and Capsular Outcome	Completed	No Results Available	Congenital Cataract	Procedure: anterior capsulorhexis sizes	Sun Yat-sen University	Both	Child		38	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	CCPMOH2010-China6	June 4, 2014	March 2011	November 2012	June 6, 2014	June 2014	No Study Results Posted	null	November 2012	Mean area of anterior/posterior capsulorhexis opening|the ratio of opacity accounting for posterior capsulorhexis opening at different visits|The area change of anterior/posterior capsulorhexis opening	https://ClinicalTrials.gov/show/NCT02158325
79	NCT01902940	Natural History in CCFDN and IBM Syndromes	Completed	No Results Available	Inclusion Body Myositis, Sporadic|Inclusion Body Myopathy, Autosomal-recessive|Inclusion Body Myopathy, Autosomal-dominant|Congenital Cataracts, Facial Dysmorphism, And Neuropathy	Other: Natural History	Ludwig-Maximilians - University of Munich	Both	Child|Adult|Senior		350	Other	Observational	Observational Model: Cohort|Time Perspective: Retrospective	CCFDN-IBM-2013	July 3, 2013	June 2013	October 2013	August 31, 2015	August 2015	No Study Results Posted	null	September 2013	Manual Muscle Strength assessed by Medical Research Council (MRC)	https://ClinicalTrials.gov/show/NCT01902940
80	NCT01867541	Intra-operative Measurements to Predict the Position of the Intraocular Lens Post-operatively	Completed	No Results Available	Cataracts		Prim. Prof. Dr. Oliver Findl, MBA|Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior		70	Other	Observational	Observational Model: Cohort|Time Perspective: Prospective	intraOP_OCT_1	May 26, 2013	December 2010	March 2013	May 29, 2013	May 2013	No Study Results Posted	null	December 2012	Correlation of intra-operative lens capsule measurements and the post-operative lens position	https://ClinicalTrials.gov/show/NCT01867541
81	NCT02042755	Pilot Study With a Diffractive Trifocal IOL (POD AY 26P FineVision)	Not yet recruiting	No Results Available	Bilateral Cataract	Device: trifocal intraocular lens	Physiol	Both	Adult|Senior		20	Industry	Observational	Observational Model: Case-Only|Time Perspective: Prospective	POD AY 26P FineVision	December 20, 2013	February 2014	December 2014	January 20, 2014	January 2014	No Study Results Posted	null	October 2014	Visual acuity|Contrast sensitivity	https://ClinicalTrials.gov/show/NCT02042755
82	NCT01786356	Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two IOLs: Hoya iMics Y-60H vs. Bausch&Lomb MI60 (MIMI)	Completed	No Results Available	Posterior Capsule Opacification|Cataract	Device: HOYA iMics Y-60H|Other: B&L MI60	Medical University of Vienna	Both	Adult|Senior		60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Subject, Investigator)	EK Nr: 931/2010	February 5, 2013	March 2008	January 2013	February 5, 2013	February 2013	No Study Results Posted	null	December 2012	posterior capsular opacification (PCO)|best corrected visual acuity (BCVA)|Nd:YAG rate	https://ClinicalTrials.gov/show/NCT01786356
83	NCT02127853	Effect of Gabapentin on Pain of the Second Cataract Surgery	Recruiting	No Results Available	Hyperalgesia	Drug: gabapentin|Drug: placebo	Seoul National University Hospital	Both	Adult|Senior	Phase 4	70	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Caregiver, Investigator)	SerialCataractGaba	April 29, 2014	July 2014	February 2016	May 10, 2015	April 2014	No Study Results Posted	null	February 2016	proportion of subjects who answer that "pain was greater" in the second eye surgery|perioperative pain	https://ClinicalTrials.gov/show/NCT02127853
84	NCT01901744	Contrast Sensitivity Assessment in Pediatric Cataract Surgery With IOL Implantation	Completed	No Results Available	Contrast Sensitivity	Procedure: Cataract Surgery	Iladevi Cataract and IOL Research Center	Both	Child		25	Other	Interventional	Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	12-008	July 1, 2013	January 2009	January 2013	July 16, 2013	July 2013	No Study Results Posted	null	July 2011	Contrast Sensitivity at 3, 6, 12 and 18 cycles per degree under photopic and mesopic conditions pre and post cataract surgery|Improvement in Best Corrected Snellen's Visual Acuity following Cataract Surgery	https://ClinicalTrials.gov/show/NCT01901744
85	NCT01936701	Comparison of the Effect of Hydrophobic Acrylic and Silicone 3-piece IOLs on Posterior Capsule Opacification	Completed	No Results Available	Posterior Capsule Opacification|Cataract	Procedure: bilateral cataract surgery	Medical University of Vienna	Both	Adult|Senior		50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Subject, Investigator)	EK Nr: 112/2011	September 3, 2013	March 2011	August 2011	September 5, 2013	September 2013	No Study Results Posted	null	March 2011	posterior capsular opacification (PCO)|best corrected visual acuity (BCVA)|Nd:YAG rate	https://ClinicalTrials.gov/show/NCT01936701
86	NCT02515045	Dropless vs. Standard Drops Contralateral Eye Study	Recruiting	No Results Available	Cataract	Drug: TriMoxiVanc|Drug: Moxifloxacin HCl 0.5%|Drug: Ilevro|Drug: Prednisolone acetate 1%	Carolina Eyecare Physicians, LLC|Science in Vision	Both	Adult|Senior	Phase 4	66	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Prevention|Masking: Open Label	CEP 14-002	July 29, 2015	January 2015	September 2015	July 31, 2015	July 2015	No Study Results Posted	null	September 2015	Change from baseline (preoperative exam) in macular thickness	https://ClinicalTrials.gov/show/NCT02515045
87	NCT02513745	Conventional Surgery vs. Verion/VerifEye	Recruiting	No Results Available	Cataract|Astigmatism	Device: Conventional|Device: Verion	Carolina Eyecare Physicians, LLC|Science in Vision	Both	Adult|Senior		60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	CEP 2014-003	July 30, 2015	June 2015	June 2016	July 30, 2015	July 2015	No Study Results Posted	null	June 2016	Residual refractive cylinder|Residual mean spherical equivalent refraction|Residual corneal astigmatism	https://ClinicalTrials.gov/show/NCT02513745
88	NCT02219997	Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration	Completed	No Results Available	Cataract	Device: Clear clip-on glasses|Device: Blue light filter clip-on glasses|Device: ACRYSOF® IQ IOL|Device: Clear IOL	Alcon Research	Both	Adult|Senior		90	Industry	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single Blind (Subject)	ILQ830-P001	August 18, 2014	October 2014	March 2015	April 2, 2015	April 2015	No Study Results Posted	null	March 2015	Change in reaction time (glare - no glare) in the subjects with ACRYSOF® IQ IOL or clear IOL|Change in reaction time (glare - no glare) in the subjects with clear IOL, with either blue light filter (BLF) or placebo filter|Change in reaction time (glare - no glare) in the subjects with ACRYSOF® IQ IOL and placebo filter, or subjects with clear IOL and BLF	https://ClinicalTrials.gov/show/NCT02219997
89	NCT02194543	High-Definition 3D Visualization System for Ophthalmic Surgery	Completed	No Results Available	Cataract		Yonsei University	Both	Adult|Senior		20	Other	Observational	Observational Model: Case Control|Time Perspective: Prospective	1-2014-0002	July 16, 2014	March 2014	July 2014	July 16, 2014	July 2014	No Study Results Posted	null	July 2014	the best corrected visual acuity	https://ClinicalTrials.gov/show/NCT02194543
90	NCT02155959	Performance of a Single-piece Toric Acrylic Intraocular Lens	Completed	No Results Available	Cataract|Corneal Astigmatism	Device: toric intraocular lens	Prim. Prof. Dr. Oliver Findl, MBA|Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior		30	Other	Observational	Observational Model: Cohort|Time Perspective: Prospective	toric_rotation_acrylic	June 12, 2013	March 2011	December 2012	June 2, 2014	June 2014	No Study Results Posted	null	December 2012	Rotational stability of the investigated toric lens|reduction in post-operative higher order aberrations	https://ClinicalTrials.gov/show/NCT02155959
91	NCT02089698	Parameters of 2 Phaco Tips Designs in Torsional Phacoemulsification	Completed	No Results Available	Cataract	Device: Mini-flared|Device: Reversed tip	Hospital Oftalmologico de Brasilia	Both	Adult|Senior	Phase 4	60	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	2014.03	March 12, 2014	September 2013	February 2014	March 15, 2014	March 2014	No Study Results Posted	null	September 2013	Early Treatment Diabetic Retinopathy (ETDRS) visual acuities|Phaco time used	https://ClinicalTrials.gov/show/NCT02089698
92	NCT02024711	EYEFILL® C. -US Viscoelastic Clinical Investigation	Completed	No Results Available	Cataract	Device: EYEFILL® C.-US Viscoelastic|Device: Healon® Viscoelastic (CONTROL)	Valeant Pharmaceuticals International, Inc.|Bausch & Lomb Incorporated	Both	Adult|Senior	Phase 3	284	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Outcomes Assessor)	EYE-C-7.00	December 27, 2013	December 2013	null	June 1, 2015	June 2015	No Study Results Posted	null	December 2014	Preservation of Endothelium|Incidence of IOP spikes >/= 30 mmHg at all postoperative follow-up visits|Cumulative rate and severity of inflammatory response at all postoperative follow-up visits|Cumulative rate and severity of other device-related adverse events at all postoperative follow-up visits	https://ClinicalTrials.gov/show/NCT02024711
93	NCT01938989	Effect of Blue Light Filtration on Visual Performance	Completed	Has Results	Cataract	Device: Clear clip-on glasses|Device: Blue light filter clip-on glasses	Alcon Research	Both	Adult|Senior		158	Industry	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Primary Purpose: Basic Science|Masking: Single Blind (Subject)	A01311	September 3, 2013	September 2013	January 2014	January 14, 2015	January 2015	January 14, 2015	null	January 2014	Photostress Recovery Time	https://ClinicalTrials.gov/show/NCT01938989
94	NCT01763411	Visual Performance of Pseudophakic Patient With Different Intraocular Lenses	Enrolling by invitation	No Results Available	Cataract|Lens Diseases|Eye Diseases		Hospital Oftalmologico de Brasilia|University of Sao Paulo	Both	Adult|Senior		80	Other	Observational	Observational Model: Cohort|Time Perspective: Retrospective	HOB-12/12|HOB03012013	January 5, 2013	January 2008	June 2016	January 10, 2015	January 2015	No Study Results Posted	ETDRS	January 2016	Visual Performance in Pseudophakic Patients With Different Intraocular Lens|Contrast sensitivity|Patient satisfaction	https://ClinicalTrials.gov/show/NCT01763411
95	NCT02314572	Visual Acuity After the Combined Binocular Implantation of +2.5 Diopters and +3.0 Diopters ReSTOR Intraocular Lenses.	Recruiting	No Results Available	Cataract	Device: Binocular cataract surgery with phacoemulsification and implantation of multifocal intraocular lenses	Charite University, Berlin, Germany	Both	Adult|Senior	Phase 4	15	Other	Interventional	Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	EA1/124/13	December 8, 2014	March 2013	June 2015	December 9, 2014	December 2014	No Study Results Posted	null	December 2014	Visual acuities in the far, intermediate and near|Mesopic vision|Scotopic contrast sensitivity|Spectacle independence in the far, intermediate and near	https://ClinicalTrials.gov/show/NCT02314572
96	NCT02058394	Retained Lens Fragments After Phacoemulsification	Active, not recruiting	No Results Available	Cataract	Procedure: Phacoemulsification	Ophthalmic Consultants, Corneal and Refractive Surgery Assoicates, PC	Both	Adult|Senior		500	Other	Observational	Observational Model: Cohort|Time Perspective: Prospective	12.08	February 4, 2014	March 2012	March 2015	February 6, 2014	February 2014	No Study Results Posted	null	December 2014	Macular edema|Intraocular inflammation|Elevated intraocular pressure|Macular Edema|Intraocular Inflammation|Elevated Intraocular Pressure	https://ClinicalTrials.gov/show/NCT02058394
97	NCT02491918	Clinical Trial : Complications of in the Bag IOL Versus Optic Capture of IOL in Pediatric Cataract Surgery	Completed	No Results Available	Posterior Capsule Opacification|Postoperative Complications	Procedure: cataract surgery|Procedure: Intraocular lens implantation	Iladevi Cataract and IOL Research Center	Both	Child		61	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Prevention|Masking: Single Blind (Subject)	13-009|2013 Research Foundation Grant	June 29, 2015	April 2013	April 2015	July 2, 2015	July 2015	No Study Results Posted	null	April 2015	Posterior capsule opacification requiring surgery|inflammation on slitlamp examination|intraocular pressure in mmHg	https://ClinicalTrials.gov/show/NCT02491918
98	NCT02578524	Satisfaction With Multifocal vs Accommodating Lens Implants 2 Years After Surgery	Completed	No Results Available	Cataract	Other: Survey	MDbackline, LLC	Both	Child|Adult|Senior		117	Other	Observational	Observational Model: Case Control|Time Perspective: Retrospective	BAU141212	October 12, 2015	January 2015	October 2015	October 15, 2015	October 2015	No Study Results Posted	null	October 2015	Satisfaction	https://ClinicalTrials.gov/show/NCT02578524
99	NCT02535819	Endothelial Cell Loss After Phacoemulsification Intra and Supracapsular	Recruiting	No Results Available	Cataracts	Procedure: Subluxation|Procedure: Divide and Conquer	Centre Hospitalier Régional Metz-Thionville	Both	Adult|Senior		294	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Supportive Care|Masking: Open Label	2015-01-CHRMT|2015-A00789-40	June 30, 2015	June 2015	June 2017	August 26, 2015	June 2015	No Study Results Posted	PERCEPOLIS	September 2016	Main Outcome Measures: postoperative Endothelial cell loss of the central corneal	https://ClinicalTrials.gov/show/NCT02535819
100	NCT01868217	A Retrospective Study to Investigate Prevalence of Capsular Bag Distention Syndrome and Its Influencing Factors	Completed	No Results Available	Capsular Bag Distention Syndrome After Cataract Surgery		Evidence Based Cataract Study Group	Both	Adult|Senior		239	Other	Observational	Observational Model: Cohort|Time Perspective: Retrospective	NSFC-81100653	May 27, 2013	January 2013	null	May 30, 2013	May 2013	No Study Results Posted	null	March 2013	Dimension of the eyeball(mm)	https://ClinicalTrials.gov/show/NCT01868217
101	NCT02332369	EyeKon Medical Inc. CTR Study	Active, not recruiting	No Results Available	Cataract Extraction	Device: Capsular Tension Ring	EyeKon Medical, Inc.	Both	Adult|Senior		125	Industry	Interventional	Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	EyeKon CTR	January 5, 2015	February 2005	null	January 5, 2015	January 2015	No Study Results Posted	CTR	March 2017	Visual Acuity|Adverse Events	https://ClinicalTrials.gov/show/NCT02332369
102	NCT02238015	Tear Film Evaluation After Phacoemulsification	Recruiting	No Results Available	Cortical Senile Cataract	Procedure: cataract surgery	Zheng Qian|Wenzhou Medical University	Both	Adult|Senior	Phase 4	60	Other	Observational	Observational Model: Case Control|Time Perspective: Prospective	WZMC2013BNZYJ	August 28, 2014	October 2013	March 2015	September 11, 2014	September 2014	No Study Results Posted	TFAP	May 2014	Phacoemulsification influence on the postoperative tear functions	https://ClinicalTrials.gov/show/NCT02238015
103	NCT02566083	Post-Approval Study of the Tecnis® Toric IOL	Not yet recruiting	No Results Available	Cataract	Device: non-toric intraocular lens|Device: toric intraocular lens	Abbott Medical Optics	Both	Adult|Senior		435	Industry	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	TIOL-202-TPAS	September 30, 2015	October 2015	August 2018	September 30, 2015	September 2015	No Study Results Posted	null	February 2018	Rate of severe visual distortions|Rate of IOL repositioning procedures due to IOL misalignment	https://ClinicalTrials.gov/show/NCT02566083
104	NCT02558712	Technology-based Eye Care Services (TECS) Compare	Not yet recruiting	No Results Available	Cataract|Macular Degeneration|Glaucoma	Other: Technology-based Eye Care Services (TECS) Protocol	Emory University	Both	Adult|Senior		600	Other	Interventional	Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Diagnostic|Masking: Open Label	IRB00080630	September 21, 2015	October 2015	September 2017	September 22, 2015	September 2015	No Study Results Posted	null	September 2017	Number of patients with accurate diagnosis of eye diseases from TECS protocol versus face to face eye exam|Number of patients appropriately referred from the TECS protocol|Number of participants with an accurate diagnosis for anterior segment disease|Inter-reader variability of the TECS protocol|Intra-reader variability of the TECS protocol|Compare auto-refraction eyeglass prescriptions with manifest-refraction eyeglass prescriptions	https://ClinicalTrials.gov/show/NCT02558712
105	NCT02558218	Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery	Completed	No Results Available	Cataract	Drug: Systane Ultra|Drug: tobradex quid (Standard)	Democritus University of Thrace	Both	Adult		80	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Prevention|Masking: Single Blind (Outcomes Assessor)	FBCat	September 15, 2015	January 2015	May 2015	September 22, 2015	September 2015	No Study Results Posted	null	May 2015	Foreign body sensation|Ocular Redness|Corneal Sensitivity	https://ClinicalTrials.gov/show/NCT02558218
106	NCT02529488	Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00	Recruiting	No Results Available	Cataract	Device: AcrySof® IQ PanOptix™ Presbyopia-Correcting IOL	Alcon Research	Both	Adult|Senior		156	Industry	Interventional	Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	ILH297-P002	August 19, 2015	September 2015	March 2017	September 15, 2015	September 2015	No Study Results Posted	null	March 2017	Mean Binocular Defocus Visual Acuity (VA)	https://ClinicalTrials.gov/show/NCT02529488
107	NCT02513134	Intraocular Lens Power Calculation Using Pre- and Intra-operative Measurements	Completed	No Results Available	Cataract		Prim. Prof. Dr. Oliver Findl, MBA|Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior		75	Other	Observational	Time Perspective: Prospective	OC3	June 2, 2014	June 2014	January 2015	July 28, 2015	July 2015	No Study Results Posted	null	January 2015	spherical equivalent in diopters between groups|Anterior chamber depth changes in mm between intra-operative OCT measurements and 1h post-operative ACD measurements|Influence of the lens thickness on IOL power calculation|Influence of post-operative tilt in degrees and decentration in mm on IOL power calculation	https://ClinicalTrials.gov/show/NCT02513134
108	NCT02466256	Intra and Postoperative Outcomes With 3 Injectors	Completed	No Results Available	Cataract	Procedure: Intraocular lens implantation|Device: Autosert Injector|Device: Royale Injector|Device: Monarch III Injector	Iladevi Cataract and IOL Research Center	Both	Adult|Senior		120	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	2014-005	June 2, 2015	December 2013	June 2014	June 8, 2015	June 2015	No Study Results Posted	null	June 2014	Incision enlargement in mm|Trypan Blue ingress into the anterior chamber in log units|Incision morphology - qualitative	https://ClinicalTrials.gov/show/NCT02466256
109	NCT02426385	Comparison of Viusal Outcomes After Implantation of the POD 26% FineVision Toric (PhysIOL) and POD 26% Toric (PhysIOL)	Recruiting	No Results Available	Cataract	Device: FineVision Toric	Physiol	Both	Adult|Senior		24	Industry	Observational	Observational Model: Case Control|Time Perspective: Prospective	TaneriPODAYFT/PODAYT	April 21, 2015	April 2015	April 2016	April 21, 2015	April 2015	No Study Results Posted	null	October 2015	The visual acuity at near of the POD 26% FINEVISION TORIC with respect to the POD 26% TORIC is improved of at least LogMAR 0.2.|The secondary objective is to measure far and intermediate visual acuity, the refraction, centration, rotational stability and to determine the amount of photic phenomena for both IOLs: POD 26% FINEVISION TORIC and POD 26% TORIC.	https://ClinicalTrials.gov/show/NCT02426385
110	NCT02424162	Comparative Study of Two Multifocal Intraocular Lens With Different Add Power	Recruiting	No Results Available	Cataract	Device: +2.75 diopters multifocal intraocular lens|Device: +3.25 diopters multifocal intraocular lens	Yonsei University	Both	Adult|Senior		60	Other	Interventional	Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	4-2014-0837	April 17, 2015	November 2014	May 2015	April 21, 2015	April 2015	No Study Results Posted	null	May 2015	Visual Acuity|Contrast sensitivity measured by the Functional Acuity Contrast Test (FACT) of the Optec 6500 view-in test system|internal aberration measured by the ray-tracing aberrometer	https://ClinicalTrials.gov/show/NCT02424162
111	NCT02409771	Clinical Trial With PRECIZON Presbyopic	Not yet recruiting	No Results Available	Cataract|Presbyopia	Device: PRECIZON Presbyopic	Ophtec BV	Both	Adult|Senior		60	Industry	Interventional	Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	AP01000538	March 12, 2015	June 2015	February 2016	June 5, 2015	June 2015	No Study Results Posted	null	February 2016	Improvement in monocular and binocular uncorrected and corrected near visual acuity|Improvement in monocular and binocular uncorrected and corrected intermediate visual acuity|Improvement in monocular and binocular uncorrected and corrected distance visual acuity|Photopic contrast sensitivity as measured by a contrast sensitivity chart|Mesopic contrast sensitivity as measured by a contrast sensitivity chart|Stability of manifest refraction (MRSE) as measured by a mean change in MRSE between visits as determined by a paired analysis|Spectacle dependency|Defocus curve|Rates of adverse events and complications|Patient satisfaction as measured by a patient satisfaction questionnaire|Quality of vision as measured by the Quality of Vision (QoV) questionnaire	https://ClinicalTrials.gov/show/NCT02409771
112	NCT02394379	Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL	Not yet recruiting	No Results Available	Cataract	Device: Trulign™ Toric IOL	Bausch & Lomb Incorporated|Valeant Pharmaceuticals International, Inc.	Both	Child|Adult|Senior	Phase 4	600	Industry	Observational	Observational Model: Cohort|Time Perspective: Prospective	858	March 9, 2015	March 2015	June 2021	March 16, 2015	March 2015	No Study Results Posted	null	March 2021	Incidence of clinically significant IOL vaulting	https://ClinicalTrials.gov/show/NCT02394379
113	NCT02393313	Rayner Toric IOL Rotational Stability	Not yet recruiting	No Results Available	Cataract|Corneal Astigmatism	Procedure: Cataract surgery|Device: Rayner T-flex Toric IOLs	Tel-Aviv Sourasky Medical Center|Rayner Intraocular Lenses Limited	Both	Adult|Senior		50	Other|Industry	Interventional	Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	0670-14-TLV	December 8, 2014	April 2015	December 2018	March 18, 2015	March 2015	No Study Results Posted	Rayner-toric	December 2017	IOL off-axis rotation|Uncorrected distance visual acuity|Corrected distance visual acuity|Subjective refraction	https://ClinicalTrials.gov/show/NCT02393313
114	NCT02390245	Improving Glaucoma Detection and Management	Enrolling by invitation	No Results Available	Glaucoma|Glaucoma Suspect|Diabetic Retinopathy|Ocular Hypertension|Cataract|Branch Retinal Vein Occlusion|Branch Retinal Arterial Occlusion|Central Retinal Vein Occlusion|Central Retinal Artery Occlusion|Epi-retinal Membrane|Macular Degeneration|Drusen|Loss of Vision	Other: Use of patient navigation and social worker	Wills Eye|Centers for Disease Control and Prevention|Westat|Public Health Management Corporation|Philadelphia Department of Public Health (PDPH)|The Health Federation of Philadelphia|Crozer-Keystone Health System|Temple Physicians Inc.	Both	Adult|Senior		300	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single Blind (Subject)	14-441	March 11, 2015	March 2015	December 2019	March 11, 2015	March 2015	No Study Results Posted	null	June 2016	To estimate the positive predictive value (PPV) of the teleophthalmology intervention for diagnosing of glaucoma|Attendance at recommended follow-up visits (Visit 4 and later)	https://ClinicalTrials.gov/show/NCT02390245
115	NCT02378636	Clinical Investigation of the Modified Rayner Monofocal Aspheric 600C (With Axis Marks) Intraocular Lens	Not yet recruiting	No Results Available	Cataract	Device: 600S	Rayner Intraocular Lenses Limited|Visioncare Research Limited	Both	Adult|Senior	Phase 4	125	Industry|Other	Interventional	Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	600C-EU-401|CFLX-2501	February 19, 2015	June 2015	August 2017	June 11, 2015	June 2015	No Study Results Posted	null	January 2016	Best Corrected Distance Visual Acuity (BCDVA)|Rotational Stability	https://ClinicalTrials.gov/show/NCT02378636
116	NCT02362334	IOL Power Calculation Using Dual Schiempflug Analyzer	Recruiting	No Results Available	Cataract		Chuncheon Sacred Heart Hospital	Both	Adult|Senior		140	Other	Observational	Time Perspective: Prospective	ChuncheonSHH	February 9, 2015	October 2014	February 2015	February 15, 2015	October 2014	No Study Results Posted	null	February 2015	Ocular parameters|Calculated IOL powers	https://ClinicalTrials.gov/show/NCT02362334
117	NCT02338882	Clinical Investigation of the Bi Flex M Multifocal IOL	Not yet recruiting	No Results Available	Cataract	Device: Bi flex M multifocal intraocular lens|Device: Bi flex 1.8 monofocal intraocular lens	Dr Phillip J Buckhurst|BMI Southend Hospital|University of Plymouth	Both	Adult|Senior	Phase 4	100	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	MC001	January 7, 2015	January 2015	January 2017	January 13, 2015	January 2015	No Study Results Posted	null	January 2017	Long term Visual Acuity|Defocus curve profiles|Long term defocus curve profiles|Contrast sensitivity|Long term Contrast sensitivity|Reading performance|Long term Reading performance|Glare|Long term Glare|Decentration of intraocular lens|Long term Decentration of intraocular lens|Visual Acuity	https://ClinicalTrials.gov/show/NCT02338882
118	NCT02270879	Multi-formula Optimization of Second Eye Refinement According to Direction of the Prediction Error of the First Eye	Completed	No Results Available	Cataract	Procedure: Phacoemulsification cataract surgery	Centro Hospitalar do Baixo Vouga	Both	Adult|Senior		156	Other	Observational	Observational Model: Cohort|Time Perspective: Retrospective	CHBaixoVouga	October 18, 2014	June 2014	July 2014	October 18, 2014	October 2014	No Study Results Posted	null	July 2014	Second eye mean absolute error (mean of the absolute value of the prediction error)|Percentage of second eyes with a post-operative refraction within ±0.50 D and ±1.00 D of the targeted refraction	https://ClinicalTrials.gov/show/NCT02270879
119	NCT02264457	A Intra-patient Comparison of Closed Loop and Plate Haptic Toric Intraocular Lenses	Not yet recruiting	No Results Available	Cataract	Device: T-flex Aspheric Toric IOL|Device: AT TORBI toric IOL	University of Plymouth|BMI Southend Hospital	Both	Adult|Senior	Phase 4	30	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	IISR-2014-003	October 8, 2014	November 2014	October 2016	October 14, 2014	October 2014	No Study Results Posted	null	January 2016	Best-corrected visual acuity|Manifest refraction|Rotational stability|IOL centration|Prevalence of posterior capsular Opacification	https://ClinicalTrials.gov/show/NCT02264457
120	NCT02238002	Assessment Of Anterior Chamber Configuration Changes After Phacoemulsification	Recruiting	No Results Available	Cataract|Shallow Anterior Chamber|Narrow Angle	Procedure: cataract surgery	Zheng Qian|Wenzhou Medical University	Both	Adult|Senior		64	Other	Observational	Observational Model: Cohort|Time Perspective: Prospective	WZMC2013QQFYJ	August 28, 2014	December 2013	March 2015	September 11, 2014	September 2014	No Study Results Posted	AOACCCAP	May 2014	anterior chamber angle parameters increased	https://ClinicalTrials.gov/show/NCT02238002
121	NCT02208232	Observation of Rotation of an Intraocular Lens	Completed	No Results Available	Cataract	Procedure: cataract surgery	Medical University of Vienna	Both	Adult|Senior		100	Other	Observational		EK Nr: 1267/2012	March 27, 2014	June 2012	December 2012	August 1, 2014	August 2014	No Study Results Posted	null	December 2012	IOL rotation	https://ClinicalTrials.gov/show/NCT02208232
122	NCT02203747	Patient Perception of Visual Distortions	Completed	No Results Available	Cataract|Astigmatism	Other: Administration of patient self-assessment	Abbott Medical Optics	Both	Adult|Senior		80	Industry	Observational	Observational Model: Case Control|Time Perspective: Prospective	TIOL-201-VPAS	July 10, 2014	August 2014	January 2015	January 16, 2015	July 2014	No Study Results Posted	null	October 2014	Rate of reported visual distortion symptoms	https://ClinicalTrials.gov/show/NCT02203747
123	NCT02155478	Comparison of the Capsular Stability With Two Different IOL Models in Patients With Pseudoexfoliation Syndrome: an Exploratory Study	Recruiting	No Results Available	Cataract	Device: ISERT 250 (HOYA, Japan): a standard IOL|Device: AMO ZCB00 IOL (Abbott Medical Optics, United States): a standard IOL	Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior		30	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Primary Purpose: Prevention|Masking: Open Label	PXF	June 2, 2014	February 2013	February 2015	June 3, 2014	June 2014	No Study Results Posted	null	February 2015	Difference between the two IOLS in postoperative IOL tilt (degrees) and decentration (mm) measured with the Purkinjemeter|Horizontal and vertical IOL tilt (in °) evaluated from AS-OCT and Scheimpflug images|Change in rhexis diameter (mm in retroillumination foto)|Change in anterior chamber depth (in mm) measured with the AC Master|Subjective evaluation of IOL - anterior capsule interconnection ( capsule overlapping the IOL optic edge in slitlamp examination)|Change in aqueous flare measured with laser flare meter	https://ClinicalTrials.gov/show/NCT02155478
124	NCT02155348	Comparison Between Bilateral Multifocal Intraocular Lenses and Pseudophakic Monovision	Recruiting	No Results Available	Cataract	Procedure: Bilateral cataract surgery with implantation of multifocal IOLs|Procedure: Bilateral cataract surgery with monovision|Device: Lentis LS-313	Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior		70	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	Lentis	June 2, 2014	June 2013	May 2015	June 3, 2014	June 2014	No Study Results Posted	null	January 2015	Spectacle independence of patients with bilateral multifocal intraocular lenses in comparison to patients with pseudophakic monovision evaluated using a questionnaire|Uncorrected and Best Corrected Distance Visual Acuity, Uncorrected and Distance Corrected Intermediate Visual Acuity, Uncorrected and Distance Corrected Near Visual Acuity between the test and the control group|Reading Speed|Stereo Vision and Contrast Sensibility	https://ClinicalTrials.gov/show/NCT02155348
125	NCT02151305	Different Hemostasis According to the Anesthetic Agents	Completed	No Results Available	Cataract|Retina Detachment|Pterygium|Keratitis|Vitreous Hemorrhage	Drug: Propofol, remifentanil|Drug: Sevoflurane	Seoul National University Bundang Hospital	Both	Adult|Senior		66	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Supportive Care|Masking: Double Blind (Subject, Investigator, Outcomes Assessor)	ROTEM_anesthesia	May 27, 2014	August 2010	April 2012	May 27, 2014	May 2014	No Study Results Posted	null	April 2012	Clotting time of ROTEM|Clot firmness time of ROTEM|Alpha angle of ROTEM|Maximum clot firmness of ROTEM|Hemoglobin|Hematocrit|Platelet count|International normalized ratio of prothrombin time|Activated partial thromboplastin time|Fibrinogen	https://ClinicalTrials.gov/show/NCT02151305
126	NCT02146599	Patient Perception of Visual Quality and Function	Completed	Has Results	Cataract	Other: Administration of patient self-assessment	Abbott Medical Optics	Both	Adult|Senior		301	Industry	Observational	Observational Model: Case-Only|Time Perspective: Prospective	QPRO-101-SIVQ	May 20, 2014	May 2014	July 2014	September 10, 2015	September 2015	July 7, 2015	null	July 2014	Use of Corrective Visual Aids (i.e., Spectacles, Contact Lenses) Post Intraocular Lens (IOL) Surgery	https://ClinicalTrials.gov/show/NCT02146599
127	NCT02084576	Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification	Completed	No Results Available	Cystoid Macular Edema|Cataract	Drug: Nepafenac|Drug: Ketorolac	Hospital Oftalmologico de Brasilia	Both	Adult|Senior	Phase 4	40	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Investigator, Outcomes Assessor)	2014.02|HOB03022014	February 18, 2014	August 2013	February 2014	March 10, 2014	March 2014	No Study Results Posted	null	August 2013	The incidence of CME was evaluated by retinal foveal thickness on optical coherence tomography (OCT)|Postoperative corrected distance visual acuity	https://ClinicalTrials.gov/show/NCT02084576
128	NCT02073266	Impact of C3F8 or SF6 Use and Length of Face-down Positioning (7 vs 14 Days Respectively) in Macular Hole Surgery.	Completed	No Results Available	Macular Holes|Visual Acuity Gain|Cataract|Complications	Procedure: Macular hole surgery using a 25 G pars plana vitrectomy, ILM peeling, fluid-air exchange followed by air-gas exchange with SF6 or C3F8.	Centre Hospitalier Universitaire de Québec, CHU de Québec	Both	Adult|Senior		59	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	2012-1429, DR-002-1266	February 25, 2014	January 2010	May 2013	February 25, 2014	February 2014	No Study Results Posted	null	December 2012	Macular hole closure and visual acuity gain|Cumulative incidence of cataract development and proportion of complications	https://ClinicalTrials.gov/show/NCT02073266
129	NCT01995630	Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients	Recruiting	No Results Available	Cataract|Spherical Aberrations|Intraocular Lenses|Depth of Focus	Device: AMO Tecnis ZA9003|Device: AMO Sensar AR40e	Medical University of Graz	Both	Adult|Senior		220	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	SIOLvsAIOL	November 21, 2013	November 2013	null	April 7, 2015	April 2015	No Study Results Posted	null	September 2015	Distance-corrected intermediate visual acuity|Distance-corrected near visual acuity|Uncorrected distance visual acuity|Corrected distance visual acuity|Uncorrected near visual acuity|Corrected near visual acuity|Pseudoaccomodation|Photopic contrast sensitivity|Mesopic contrast sensitivity|Spherical aberrations|High order aberrations	https://ClinicalTrials.gov/show/NCT01995630
130	NCT01979172	Comparison of Intraocular Lens Power Calculation Methods After Corneal Laser Refractive Surgery in Axial and Refractive Ammertropia	Recruiting	No Results Available	Cataract|Refractive Errors		The National Eye Hospital, Cairo, Egypt	Both	Child|Adult|Senior		400	Other	Observational	Time Perspective: Prospective	LASIK/IOL	November 3, 2013	November 2013	March 2014	November 3, 2013	November 2013	No Study Results Posted	null	March 2014	Best Selected IOL calculation formula	https://ClinicalTrials.gov/show/NCT01979172
131	NCT01978106	Comparisons of the Astigmatic Power of Toric Intraocular Lens Using Three Toric Calculators: AcrySof, TECNIS, and iTrace Toric Calculator	Completed	No Results Available	Cataract|Astigmatism		Yonsei University	Both	Adult|Senior		100	Other	Observational	Observational Model: Cohort|Time Perspective: Retrospective	1-2013-0041	October 31, 2013	January 2013	April 2013	November 6, 2013	November 2013	No Study Results Posted	null	April 2013	Difference of toric intraocular lens power between three toric calculators	https://ClinicalTrials.gov/show/NCT01978106
132	NCT01767012	Aqueous Flare of a Hydrophobic Acrylic Single-piece Open-loop IOL With Modified Material Surface Properties	Completed	No Results Available	Cataract|Diabetes|Pseudoexfoliation Syndrome	Device: Polylens EC-HY10-PAL (coated)|Device: Polylens EC-Y10-PAL (uncoated)	Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior	Phase 4	40	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	Viros_POLYLENS	January 6, 2013	August 2010	November 2012	January 9, 2013	January 2013	No Study Results Posted	POL	August 2012	Amount of aqueous flare measured with a Laser flare meter|Anterior capsule opacification (measured as brightness of anterior capsular reflect on slitlamp photographs)	https://ClinicalTrials.gov/show/NCT01767012
133	NCT02487160	Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens	Not yet recruiting	No Results Available	Cataracts|Presbyopia	Device: SBL-3 multifocal intraocular lens|Device: Control monofocal intraocular lens	Lenstec Incorporated	Both	Adult|Senior	Phase 2|Phase 3	510	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	SBL-INI-02-13	June 25, 2015	August 2015	August 2017	August 18, 2015	August 2015	No Study Results Posted	null	August 2016	photopic, distance corrected, monocular near visual acuity|presence or absence of adverse events|photopic, distance corrected, monocular intermediate visual acuity|photopic, best corrected, monocular distance visual acuity|Proportion of subjects who are independent of spectacles	https://ClinicalTrials.gov/show/NCT02487160
134	NCT02109276	Study of the Effect of Aspheric Lenses in Patients With Fuch's Dystrophy	Recruiting	No Results Available	Fuch's Endothelial Dystrophy|Cataracts	Device: Spheric Sensar(R) 3-piece IOL|Device: Aspheric Tecnis(R) 3-piece IOL	Queen's University	Both	Adult|Senior		72	Other	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	OPTH-151-14	April 7, 2014	April 2014	September 2017	October 1, 2015	October 2015	No Study Results Posted	null	June 2017	Change in contrast sensitivity.|Higher Order Aberrations	https://ClinicalTrials.gov/show/NCT02109276
135	NCT02042703	Imaging Lens Deposits in Exfoliation Syndrome	Recruiting	No Results Available	Exfoliation Syndrome|Primary Open Angle Glaucoma|Cataracts	Device: anterior segment OCT	Duke University	Both	Adult|Senior		60	Other	Observational	Observational Model: Case Control|Time Perspective: Prospective	Pro00050919	January 21, 2014	February 2014	June 2016	March 5, 2015	March 2015	No Study Results Posted	null	June 2016	Amount of exfoliation deposits on the lens as measured by AS-OCT	https://ClinicalTrials.gov/show/NCT02042703
136	NCT01936740	Comparison of Two Phacoemulsification-methods: HF EasyTip 2.2mm vs. HF EasyTip 2.8mm	Completed	No Results Available	Cataracts	Procedure: cataract surgery	Medical University of Vienna	Both	Adult|Senior		50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Subject, Investigator)	Ek Nr: 1268/2012	September 3, 2013	June 2012	June 2013	September 5, 2013	September 2013	No Study Results Posted	null	October 2012	phacoemulsification time|effective phacoemulsification time|fluid volume|postoperative corneal oedema|postoperative endotheial cell loss	https://ClinicalTrials.gov/show/NCT01936740
137	NCT01936727	Comparison of Two Phacoemulsification-methods: EasyTip 2.2mm vs. Infusion Assisted EasyTip 2.2mm	Completed	No Results Available	Cataracts	Procedure: cataract surgery	Medical University of Vienna	Both	Adult|Senior		50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Subject, Investigator)	EK Nr:1053/2011	September 3, 2013	December 2011	August 2012	September 5, 2013	September 2013	No Study Results Posted	null	February 2012	phacoemulsification time|effective phacoemulsification time|fluid volume|postoperative corneal oedema|postoperative endotheial cell loss	https://ClinicalTrials.gov/show/NCT01936727
138	NCT01936714	Comparison of Two Phacoemulsification-methods: Low Fluidic EasyTip 2.2mm vs. High Fluidic EasyTip 2.2mm	Completed	No Results Available	Cataracts	Procedure: cataract surgery	Medical University of Vienna	Both	Adult|Senior		50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Subject, Investigator)	EK Nr: 2007/2012	September 3, 2013	February 2013	September 2013	April 9, 2015	April 2015	No Study Results Posted	null	March 2013	phacoemulsification time|effective phacoemulsification time|fluid volume|postoperative corneal oedema|postoperative endotheial cell loss	https://ClinicalTrials.gov/show/NCT01936714
139	NCT01846078	Accuracy of Holladay 2 Formula in the Absence of Lens Thickness	Completed	No Results Available	Cataracts	Device: optical biometric measurement (IOLMaster)	Mahidol University	Both	Adult|Senior		143	Other	Interventional	Intervention Model: Single Group Assignment|Primary Purpose: Diagnostic|Masking: Open Label	Si343/2012	April 30, 2013	June 2012	December 2012	May 2, 2013	April 2013	No Study Results Posted	null	September 2012	mean absolute error of Holladay2 formula	https://ClinicalTrials.gov/show/NCT01846078
140	NCT02434588	Evaluation of an Iris Dilatation Ring in Cataract Surgery (ADICC-ID)	Recruiting	No Results Available	Small Pupil	Device: Bhattacharjee ring	Fondation Ophtalmologique Adolphe de Rothschild	Both	Adult|Senior		20	Other	Interventional	Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	JFO_2014-27|ID-RCB 2014-A01880-47	April 14, 2015	April 2015	null	April 30, 2015	April 2015	No Study Results Posted	ADICC-ID	May 2016	Proportion of patients with dilated iris ≥ 6 mm|Proportion of patients with dilated iris ≥ 6 mm after instillation of dilating eye drops|Proportion of patients with ≥ 6mm iris dilation after surgery|Proportion of patients with iris retraction ≤ 4 mm immediately|Surgeon feeling operational conditions on an visual analogic scale|Change for Malyugin ring during surgery	https://ClinicalTrials.gov/show/NCT02434588
141	NCT01808560	Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery	Completed	No Results Available	Blepharitis|Dry Eye Syndrome	Device: LipiFlow Pre-Treatment|Device: LipiFlow Post-treatment	TearScience, Inc.	Both	Adult|Senior		34	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Crossover Assignment|Primary Purpose: Treatment|Masking: Open Label	LF005	March 7, 2013	March 2013	January 2015	February 4, 2015	February 2015	No Study Results Posted	null	January 2015	Mean change in total meibomian gland score|Mean change in Ocular Surface Disease Index (OSDI) questionnaire score	https://ClinicalTrials.gov/show/NCT01808560
142	NCT02526706	Using a Type of Blue Dye to Observe Bleb Function During Cataract Surgery	Not yet recruiting	No Results Available	Glaucoma	Other: VisionBlue	Wills Eye	Both	Adult|Senior		20	Other	Interventional	Intervention Model: Single Group Assignment|Masking: Open Label	15-494	August 10, 2015	August 2015	August 2016	August 14, 2015	August 2015	No Study Results Posted	null	August 2016	Change in intraocular pressure (IOP) post surgery|The Indiana Bleb Appearance Grading System (IBAGS) will be used for bleb grading|Change in Glaucoma medication from pre to post surgery	https://ClinicalTrials.gov/show/NCT02526706
143	NCT01988246	Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery	Recruiting	No Results Available	Diabetic Retinopathy	Drug: Aflibercept|Drug: Sham	Rishi Singh|Regeneron Pharmaceuticals|The Cleveland Clinic	Both	Adult|Senior	Phase 1|Phase 2	30	Other|Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Prevention|Masking: Single Blind (Subject)	PROMISE Trial	October 30, 2013	December 2013	September 2016	August 31, 2015	August 2015	No Study Results Posted	PROMISE	June 2016	Safety and Efficacy|Visual Acuity	https://ClinicalTrials.gov/show/NCT01988246
144	NCT02495220	Efficacy of Dexmedetomidine for Postoperative Analgesia in Infantile Cataract Surgery	Recruiting	No Results Available	Postoperative Pain|Postoperative Vomiting	Drug: SB dexmedetomidine bupivacaine block|Drug: intravenous dexmedetomidine	Assiut University	Both	Child	Phase 2|Phase 3	80	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Prevention|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	IRB00008711068	July 3, 2015	July 2015	November 2015	July 10, 2015	July 2015	No Study Results Posted	null	November 2015	Postoperative assessment for number of infants requiring rescue analgesia .|CRIES pain scale score|vomiting scale score|Number of oculocardiac reflex(OCR)events(acute reduction in heart rate of >20%).	https://ClinicalTrials.gov/show/NCT02495220
145	NCT01778959	Methods to Manage Intra-operative Floppy-iris Syndrome and Poor Pupil Dilation in Cataract Surgery	Recruiting	No Results Available	Management of Intraoperative Floppy-iris Syndrome and Small Pupils With Different Mechanical Devices	Device: Malyugin Ring|Device: Iris hooks|Device: standard OVD|Device: OVD	Vienna Institute for Research in Ocular Surgery	Both	Adult|Senior		80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator, Outcomes Assessor)	IFIS	January 25, 2013	February 2012	December 2013	January 25, 2013	January 2013	No Study Results Posted	IFIS	July 2013	Mean difference in flare (pre-operatively to 1 day post-operatively) between the OVD and the device group	https://ClinicalTrials.gov/show/NCT01778959
146	NCT01841437	Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry	Recruiting	No Results Available	Primary Open-angle Glaucoma	Device: iStent	Glaukos Corporation	Both	Child|Adult|Senior	Phase 4	500	Industry	Observational	Observational Model: Cohort|Time Perspective: Prospective	GTS100-PAR	April 24, 2013	September 2013	August 2019	June 3, 2015	June 2015	No Study Results Posted	null	August 2019	Rate of sight-threatening adverse events|Other ocular adverse events	https://ClinicalTrials.gov/show/NCT01841437
147	NCT02209961	Combined Ex-PRESS Implantation Alone or With Phacoemulsification for Glaucoma Associated With Cataract	Enrolling by invitation	No Results Available	Glaucoma and Ocular Hypertension		Hillel Yaffe Medical Center	Both	Adult|Senior		100	Other	Observational	Observational Model: Cohort|Time Perspective: Prospective	0054-13	March 19, 2014	March 2014	June 2016	August 5, 2014	August 2014	No Study Results Posted	null	June 2015	Intraocular pressure change in Ex-PRESS shunt implantation alone or combined cataract and glaucoma surgery in patients with medically uncontrolled glaucoma and cataract .	https://ClinicalTrials.gov/show/NCT02209961
148	NCT02024464	Compare the Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Having Cataract Surgery (Hydrus III)	Recruiting	No Results Available	Primary Open Angle Glaucoma|Pseudoexfoliative Glaucoma|Pigmentary Dispersion Glaucoma	Device: Hydrus Microstent|Device: iStent Trabecular Micro Bypass	Ivantis, Inc.	Both	Adult|Senior		300	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	CP-10-002	December 20, 2013	August 2011	January 2017	December 27, 2013	December 2013	No Study Results Posted	Hydrus III	December 2015	Intraocular pressure at Month 12|Proportion of patients requiring supplemental medication.	https://ClinicalTrials.gov/show/NCT02024464
149	NCT01841450	Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery	Recruiting	No Results Available	Primary Open Angle Glaucoma	Device: iStent|Procedure: Cataract surgery	Glaukos Corporation	Both	Adult|Senior	Phase 4	360	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	GTS100-PAS2	April 24, 2013	July 2013	December 2023	June 3, 2015	June 2015	No Study Results Posted	null	December 2023	Rate of sight-threatening adverse events|Other adverse events	https://ClinicalTrials.gov/show/NCT01841450
150	NCT01784926	Late Dislocation of Intraocular Lens (IOL) Following Cataract Surgery: an Evaluation of Two Different Surgical Methods	Recruiting	No Results Available	IOL-dislocation	Procedure: Scleral suturing versus IOL exhange	Oslo University Hospital	Both	Child|Adult|Senior		80	Other	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	2012/1981	January 29, 2013	January 2013	December 2020	February 18, 2013	February 2013	No Study Results Posted	null	December 2015	Best corrected visual acuity|Intraocular pressure (IOP)|Endothelial density|Keratometry|Questionaire Visual function (VF-14)|IOL location	https://ClinicalTrials.gov/show/NCT01784926
151	NCT01942642	Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery	Completed	No Results Available	Meibomian Gland Dysfunction		Yonsei University	Both	Adult|Senior		48	Other	Observational	Observational Model: Case-Only|Time Perspective: Prospective	4-2012-0690	August 29, 2013	November 2012	April 2013	September 13, 2013	September 2013	No Study Results Posted	null	April 2013	Ocular parameters	https://ClinicalTrials.gov/show/NCT01942642
152	NCT02049333	Cataract Surgery vs Cataract Surgery With ECPL for Treatment of Plateau Iris Configuration or Syndrome	Completed	No Results Available	Glaucoma	Procedure: Phacoemulsification|Procedure: Endoscopic Cycloplasty (ECPL)	Credit Valley EyeCare	Both	Adult|Senior		26	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Single Blind (Subject)	ECPLateau10.1	January 27, 2014	November 2010	November 2013	January 29, 2014	January 2014	No Study Results Posted	null	November 2013	Anterior Chamber Angle Depth (nasal angle)|Number of glaucoma medications|Intraocular pressure (IOP)	https://ClinicalTrials.gov/show/NCT02049333
153	NCT01882413	A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal	Completed	No Results Available	Dry Eye Syndromes	Other: No intervention	Allergan	Both	Adult|Senior		204	Industry	Observational	Observational Model: Case-Only|Time Perspective: Prospective	GMA-RES-012-001	June 18, 2013	June 2013	March 2014	April 15, 2014	April 2014	No Study Results Posted	REVEAL	March 2014	Percentage of Patients with a Presence of Matrix Metalloproteinase-9 (MMP-9) in the Study Eye|Subject Evaluation of Symptoms of Dryness on a 5-Point Scale|Ocular Surface Disease Index© (OSDI©) Questionnaire Score|Tear Film Break-up Time (TFBUT)|Corneal Staining on a 6-Point Scale|Conjunctival Staining on a 6-Point Scale|Tear Wetting Using Schirmer's test|Artificial Tear Use|History of Punctal Plug Use	https://ClinicalTrials.gov/show/NCT01882413
154	NCT02234635	Visual Quality Change of Eyes Implanted With Diffractive Multifocal Intraocular Lens After Cataract Surgery	Recruiting	No Results Available	Dry Eye|Vision Disorders|Quality of Life	Other: Diffractive multifocal IOLs group	Wenzhou Medical University	Both	Adult|Senior		50	Other	Interventional	Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Open Label	VQIOL-21	July 31, 2014	August 2012	February 2015	September 8, 2014	September 2014	No Study Results Posted	null	September 2014	To evaluate the Visual Quality Change of Eyes Implanted With Diffractive Multifocal Intraocular Lens|To evaluate the Tear-film Quality Dynamics of Eyes Implanted With Diffractive Multifocal Intraocular Lens	https://ClinicalTrials.gov/show/NCT02234635
155	NCT02034019	Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery	Completed	No Results Available	Post Ocular Surgical Inflammation and Pain	Drug: Dexamethasone|Drug: Punctum Plug	Ocular Therapeutix, Inc.	Both	Adult|Senior	Phase 3	247	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	OTX-13-002	January 9, 2014	February 2014	March 2015	March 10, 2015	March 2015	No Study Results Posted	null	March 2015	Absence of cells in anterior chamber of the study eye|Absence of pain in study eye|Cells in the anterior chamber in the study eye|Pain in the study eye	https://ClinicalTrials.gov/show/NCT02034019
156	NCT02089113	Second Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery	Completed	No Results Available	Post Ocular Surgical Inflammation and Pain	Drug: Dexamethasone|Device: Punctum Plug	Ocular Therapeutix, Inc.	Both	Adult|Senior	Phase 3	240	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	OTX-14-003	March 13, 2014	April 2014	April 2015	May 15, 2015	October 2014	No Study Results Posted	null	January 2015	Absence of cells in anterior chamber of the study eye|Cells in the anterior chamber in the study eye|Pain in the study eye	https://ClinicalTrials.gov/show/NCT02089113
157	NCT02412215	Rotational Stability After Nanoflex Collamer Toric Intraocular Lens Implantation in Astigmatic Patients	Recruiting	No Results Available	Astigmatism	Procedure: Phacoemulsification with toric Nanoflex IOL implantation|Device: NanoFlex toric Intraocular Lens	University of Turin, Italy	Both	Adult|Senior		60	Other	Interventional	Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label	0026769	March 29, 2015	March 2015	September 2017	April 8, 2015	April 2015	No Study Results Posted	T-IOL	March 2017	Change in rotational stability of the toric intraocular lens (T-IOL).|Correction of the astigmatism.	https://ClinicalTrials.gov/show/NCT02412215
158	NCT02406430	Prognostic Factors in Epiretinal Membrane Surgery	Completed	No Results Available	Epiretinal Membranes	Procedure: a combined cataract and ERM surgery	Centre Hospitalier Universitaire Dijon	Both	Adult|Senior		142	Other	Observational	Observational Model: Case-Only|Time Perspective: Retrospective	CREUZOT 2013	March 30, 2015	April 2009	null	March 30, 2015	March 2015	No Study Results Posted	null	October 2013	Best corrected visual acuity|To set up a predictive score for a >= 20/20 best corrected visual acuity	https://ClinicalTrials.gov/show/NCT02406430
159	NCT02164994	Prospective Evaluation of the Long-term Effectiveness of the Femtosecond Laser-assisted Arcuate Incisions	Recruiting	No Results Available	Astigmatism		Technolas Perfect Vision GmbH	Both	Adult|Senior		100	Industry	Observational	Observational Model: Cohort|Time Perspective: Prospective	1402	June 13, 2014	April 2014	November 2015	April 23, 2015	April 2015	No Study Results Posted	null	September 2015	Postoperative keratometric cylinder|Postoperative Manifest Cylinder|Postoperative Objective Cylinder	https://ClinicalTrials.gov/show/NCT02164994
160	NCT01885780	Prospective Evaluation of the Effectiveness of the Femtosecond Laser-assisted Refractive Astigmatic Keratotomy.	Completed	No Results Available	Astigmatism	Device: Laser-assisted Astigmatic keratotomy	Technolas Perfect Vision GmbH	Both	Adult|Senior	Phase 4	45	Industry	Interventional	Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	1212	June 11, 2013	January 2013	March 2014	May 30, 2014	May 2014	No Study Results Posted	null	March 2014	Keratomic corneal astigmatism|Topographic corneal and subjective cylinder	https://ClinicalTrials.gov/show/NCT01885780
161	NCT01836042	Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort	Completed	No Results Available	Primary Open Angle Glaucoma		Glaukos Corporation	Both	Child|Adult|Senior		108	Industry	Observational	Observational Model: Cohort|Time Perspective: Retrospective	GTS100-PAS	April 17, 2013	July 2013	April 2014	May 18, 2015	May 2015	No Study Results Posted	null	April 2014	Rate of sight-threatening adverse events	https://ClinicalTrials.gov/show/NCT01836042
162	NCT02310815	ReSure Sealant Post Approval Study	Enrolling by invitation	No Results Available	Adverse Events	Device: ReSure Sealant	Ocular Therapeutix, Inc.	Both	Adult|Senior		598	Industry	Observational	Observational Model: Case-Only|Time Perspective: Prospective	OTX-13-003	December 3, 2014	December 2014	null	February 5, 2015	February 2015	No Study Results Posted	Clinical PAS	April 2016	Anterior chamber cells greater than level 1+ persisting at Visit 2 (≥ Day 20)|Hypotony (≤ 5 mmHg)|Ocular discomfort|Surgical reintervention	https://ClinicalTrials.gov/show/NCT02310815
163	NCT02228577	Safety and Performance Study of the CyPass System Applier Model 241	Completed	No Results Available	Open Angle Glaucoma (OAG)		Transcend Medical, Inc.	Both	Child|Adult|Senior		172	Industry	Observational	Observational Model: Case-Only|Time Perspective: Retrospective	TMI-14-01	August 27, 2014	August 2014	October 2014	May 11, 2015	May 2015	No Study Results Posted	RePASS	October 2014	Ocular adverse events in the study eye	https://ClinicalTrials.gov/show/NCT02228577
164	NCT02309736	ReSure Sealant Device Exposure Registry	Not yet recruiting	No Results Available	Endophthalmitis	Device: ReSure Sealant	Ocular Therapeutix, Inc.	Both	Child|Adult|Senior		4857	Industry	Observational	Observational Model: Case-Only|Time Perspective: Prospective	OTX-14-002	December 3, 2014	January 2016	null	October 6, 2015	October 2015	No Study Results Posted	null	January 2019	Occurrence of endophthalmitis	https://ClinicalTrials.gov/show/NCT02309736
165	NCT01820065	Long-term Evaluation of Single-piece ACrysof IOL Implantation on Development of Posterior Capsule Opacification	Completed	No Results Available	Posterior Capsule Opacification After Phacoemulsification and IOL Implantation	Procedure: Cataract surgery with IOL implantation	Iladevi Cataract and IOL Research Center	Both	Adult|Senior		390	Other	Observational	Observational Model: Cohort|Time Perspective: Prospective	05-003	March 25, 2013	June 2005	October 2011	March 27, 2013	March 2013	No Study Results Posted	null	October 2011	Posterior Capsule Opacification|EPCO Score and EPCO area with total on and part on anterior capsulorhexis cover over optic	https://ClinicalTrials.gov/show/NCT01820065
166	NCT02434692	Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)	Recruiting	No Results Available	Primary Open Angle Glaucoma (POAG)	Device: ARGOS-IO system	Implandata Ophthalmic Products GmbH	Both	Adult|Senior		22	Industry	Interventional	Endpoint Classification: Safety Study|Intervention Model: Single Group Assignment|Primary Purpose: Diagnostic|Masking: Open Label	ARGOS-02|CIV-13-11-011719	September 2, 2014	May 2014	December 2015	April 30, 2015	April 2015	No Study Results Posted	null	December 2015	Safety|Incidence of adverse events|Severity of adverse events|Performance	https://ClinicalTrials.gov/show/NCT02434692
167	NCT02418871	Evaluation of the FluidVisionTM AIOL With an Improved Injector	Active, not recruiting	No Results Available	Presbyopia	Device: FluidVisionTM accommodating intraocular lens	PowerVision	Both	Adult|Senior	Phase 3	60	Industry	Interventional	Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	AIOL-2015-1	April 9, 2015	April 2015	October 2018	September 14, 2015	September 2015	No Study Results Posted	null	September 2015	Visual Acuity	https://ClinicalTrials.gov/show/NCT02418871
168	NCT02163824	Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation	Completed	No Results Available	Ocular Infections, Irritations and Inflammations	Drug: KPI-121	Kala Pharmaceuticals, Inc.	Both	Adult|Senior	Phase 3	380	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)	KPI-121-C-001	June 12, 2014	May 2014	March 2015	March 30, 2015	March 2015	No Study Results Posted	Hawaii-1	December 2014	Resolution of Anterior Chamber Cells|Resolution of Ocular Pain|Resolution of both Anterior Chamber Cell and Ocular Pain|Resolution of both Anterior Chamber Cells and Ocular Pain	https://ClinicalTrials.gov/show/NCT02163824
169	NCT02065375	RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery	Completed	No Results Available	Inflammation and Pain Following Ocular Surgery	Drug: RTA 408 0.5% Ophthalmic Suspension|Drug: RTA 408 1.0% Ophthalmic Suspension|Drug: Placebo	Reata Pharmaceuticals, Inc.|AbbVie	Both	Adult|Senior	Phase 2	109	Industry	Interventional	Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Investigator)	RTA 408-C-1307	February 13, 2014	February 2014	September 2014	October 30, 2014	October 2014	No Study Results Posted	null	September 2014	Anterior Chamber Cell Count|Pain	https://ClinicalTrials.gov/show/NCT02065375
170	NCT02049567	Evaluation of the FluidVision Accommodating Lens	Active, not recruiting	No Results Available	Presbyopia	Device: Intraocular Lens Implantation	PowerVision	Both	Adult|Senior	Phase 2|Phase 3	115	Industry	Interventional	Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label	CTP01725	January 28, 2014	January 2014	July 2017	April 13, 2015	April 2015	No Study Results Posted	AIOL-2009-1	January 2016	Objective accommodative amplitude|Best corrected distance visual acuity of logMAR of 0.3 or better	https://ClinicalTrials.gov/show/NCT02049567
